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ABSTRACT 
The use of enzymes as catalysts in various synthetic procedures appears to be an economical and 
profound way of providing selective processes in synthetic organic chemistry. Enzymes provide 
alternative and sustainable processes and have helped to avoid limitations encountered when using 
traditional heterogeneous and homogeneous catalysts; this includes the use of toxic substances, use of 
expensive heavy metals, extensive use of harmful organic solvents, harsh reaction conditions, and also 
poor selectivity of many catalysts. 
Laccases are oxidoreductase enzymes capable of catalysing oxidation reactions of several low molecular 
weight organic compounds such as polyphenols, aminophenols, methoxyphenols, polyamines, and 
lignin-related molecules. The catalytic process of these enzymes occurs though a one-electron oxidation 
and water is released as the only by-product.  
In this project we investigated the range and limitations of applications of laccase enzymes in organic 
synthesis. The project focus was on method development for cross-coupling reactions of Carbon, 
Nitrogen, Oxygen, and Sulphur substituted aromatic compounds. The laccase facilitated synthesis of five 
classes of compounds; biaryl compounds, benzoxazoles, benzimidazoles, benzothiazoles, and 
aminobenzoquinones, was investigated. The research explored the synthesis of biaryl compounds from 
simple substituted phenol substrates. The optimal reaction conditions for the synthesis of biaryl 
compounds from simple phenols were investigated. A condensation reaction between 2-aminophenol 
and aryl aldehyde derivatives was performed with the aim of synthesising 2-arylbenzoxazole derivatives; 
however various aminophenol derivatives were formed as the phenolic Schiff base failed to cyclise. 
Alternatively, when including the laccase-mediator ABTS, dimerization of 2-aminophenol to 2-amino-
3H-phenoxazin-3-one (4) occurred.  
 
A chemo-selective method for the synthesis of 2-aryl-1H-benzimidazoles from condensation of 2-
phenelynediamine and aryl aldehydes was developed using laccase as an oxidising catalyst. Optimal 
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conditions for synthesising 2-aryl-1H-benzimidazoles were identified while using acetate buffer (0.1 M, 
pH 4.5), acetonitrile as a co-solvent and the commercial laccase preparation Novoprime base 268.  
A modern and practical laccase-catalysed route suitable for the synthesis of 2-arylbenzothiazoles was 
developed. To the best of our knowledge, the laccase catalysed method for preparation of 2-
arylbenzothiazole derivatives derived from condensation–dehydration reaction of 2-aminothiophenol 
with aryl-aldehydes has not been reported before. The method described is green, effective and simply 
requires a facile work-up routine, utilising solvents such as acetonitrile and DMF as co-solvents. 
Finally, factors limiting yields for the synthesis of aminobenzoquinones were investigated by varying the 
reaction conditions.  The laccase catalysed nuclear diamination of aromatic hydrobenzoquinones with 
aliphatic and aromatic amine molecules was investigated under mild reaction conditions using 
commercial laccases from Novozymes (Suberase®, Denilite® II Base, and Novoprime Base 268). 
Conducting the reactions under dilute conditions, sequential addition of enzyme and substrate over time 
and using Novoprime Base 268 as our laccase increased the yields to up to 100%.   
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C h a p t e r  1  
INTRODUCTION 
1.1. General Introduction 
In the present period, using enzymes to address modern challenges experienced in complex synthetic 
organic chemistry and biotechnology has proven valuable. Over the years, enzyme-catalysed reactions 
have become one of the alternate sustainable reaction processes and have helped to minimize the 
release of hazardous substances into the environment [1].  Laccases (benzenediol:oxygen 
oxidoreductases, EC1.10.3.2) are well recognized oxidoreductase enzymes belonging to the family of 
blue multi-copper-containing oxidases. These enzymes bear a distinctive redox ability to catalyse the 
oxidation reactions of several low molecular weight organic substrates utilising atmospheric oxygen as 
the electron acceptor in the process while releasing water as the by-product [2]. The substrates 
catalysed by laccases include a variety of organic and inorganic substrates such as polyphenols, 
aminophenols, methoxyphenols, polyamines, and lignin-related molecules and this is done through a 
process of one-electron oxidation [1, 3]. Because of their high level of selectivity and their effectual 
and environment friendly processes, laccases have been shown to have a large and increasing variety of 
industrial applications ranging from textile to the pulp and paper industries and from food industries 
to bioremediation processes [4, 5]. 
 
1.2. Distribution of  Laccases in nature  
In nature laccases are utilized in a number of biological processes. They carry out a variety of cellular 
processes in fungi; these include pigment production, sporulation and delignification [6]. The laccases 
commonly described in literature were isolated from fungi, but they have also been reported to be 
widely distributed in a range of many plants, insects and bacteria [2]. Reports indicate their presence in 
lichens [7]; oysters [8]; metagenome libraries of bovine rumen; and sponges [9]. In 1883 Yoshida first 
discovered laccase as an element of the resin ducts in the sap of the Japanese lacquer tree Rhus 
vernicifera, since then its biochemistry, structure, activity, and applications have been studied 
considerably [1, 4]. The typical laccases found in plants have been identified in apples, potatoes, trees, 
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cabbages, mango, lacquer, prune, sycamore, pine, peach, beets, turnips and many other plant species 
[3]. It is believed that laccases play an important role in plant species as they are primarily involved in 
lignin formation and this occurs through a radical-based mechanism [2].  
A few years after Yoshida’s discovery of plant laccase, a French pharmacologist and bacteriologist 
Gabriel Bertrand discovered the first fungal laccase in 1896, and since then the majority of the laccases 
characterised to date have been isolated from fungi. The wood-rooting fungi are the most common 
laccase producers; more than 100 laccases isolated were fungal laccases and the laccase from wood-
rotting fungi are one of the most frequently purified [1]. The sources of fungal laccase include 
ascomycetes, deuteromycetes, and basidiomycetes fungi, where the wood-rotting fungi Trametes 
versicolor, T. hirsuta (C. hirsutus), T. ochracea, T. villosa, T. gallica, Cerrena maxima, Coriolopsis polyzona, Lentinus 
tigrinus, and Pleurotus eryngii are the common laccase producers and also the most reported in literature 
[1-3]. In fungi, laccases carry out a variety of procedures such as degrading lignin molecules, mutagenic 
processes, stress defence, and also melanin synthesis [10, 11].  
Laccase activity has been observed in bacteria including Azospirillum lipoferum, Bacillus subtilis, 
Marinomonas mediterranea, Streptomyces griseus, and Escherichia coli [2-3]. Their role in bacteria includes 
processes such as copper homeostasis in Escherichia coli [12], morphogenesis, and cell pigmentation 
[13].  
More recently proteins with characteristic laccase features and properties have been categorized in 
insects of the classes that include Calipora, Lucilia, Manduca, Papilio, Schistocerca, Bombyx and Rhodnius [3, 
4]. 
1.3. The structure of Laccase 
Laccases are intra or extracellular glycosylated proteins which are often found as isozymes that 
oligomerize to form different protein complexes where less saccharide are found in bacterial and 
fungal enzymes than in plant enzymes [1, 3]. Normally the monosaccharides found in the carbohydrate 
polymers include hexoamines, glucose, arabinose, galactose, and fucose [3]. The average molecular 
weight observed for the glycosylated protein monomers is usually 50-130 KDa [2]. It is believed that 
glycosylation serves an important role in the molecular structure of laccase as it is responsible for the 
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stability of the enzyme. In addition it contributes towards proteolytic susceptibility, copper retention, 
and protection against enzyme inactivation by free radicals, and secretion [2, 3].   
Laccase in its purified form generally exhibits a characteristic blue colour; this is due the extreme 
electronic absorption of the Cu-Cu linkages [4]. The active site of laccase is composed of four copper 
atoms which are classified into three redox sites (T1, T2 and T3) using spectroscopic techniques such 
as UV/Vis and electron paramagnetic resonance (EPR) [2-3].  
 
Figure 1: Laccase CotA Active site from Bacillus subtilis [1]. 
The type 1 copper atom (T1) gives the enzyme its typical intense blue colour due to its strong 
electronic absorption at 600 nm and it is detectable by EPR spectroscopy [3]. The observed strong 
absorption of the T1 copper atom is mainly associated with the copper-cysteine bond since the T1 
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copper forms some kind of a trigonal coordination with a single cysteine and two histidine ligands. In 
fungal laccases the axial ligand(s) is phenylalanine or leucine and in bacterial laccases (CotA) it is 
methionine [2]. Copper of the first type has been found to be the site with a high redox potential of 
about +740 mV, hence it is the site where oxidation of the substrate takes place [2, 3]. Copper of the 
second type does not exhibit any colour; shows weak absorption in the visible region but it can be 
detected by EPR. On the other hand copper of the third type is EPR undetectable and this is because 
it is comprised of two copper atoms which exhibit a form of anti-ferromagnetism due to the bridging 
hydroxyl ligand coupling them, hence they are diamagnetic and cannot be detected on EPR [2]. 
Together the type two (T2) and the type three (T3) copper atoms form what is known as a tri-nuclear 
cluster; which appears to be the site where atmospheric oxygen binds and four-electron reduction to 
water occurs [2, 3]. Studies show that the type 2 copper site is bound to two nitrogen atoms 
(histidines) and in the type 3 site copper atoms are coordinate with six histidine ligands [2]. The type 2 
copper centre is believed to provide an important structural purpose of stabilizing the type 3 copper 
centre and other studies show that the methionine ligand help to stabilize the type 1 copper centre [3]. 
1.4. Mode of  action of  laccases 
The enzyme catalysis of laccases takes place through the attack of phenolic compounds resulting in 
oxidation of alpha carbon, cleavage of aryl-aryl and alpha-beta bonds [14]. The mechanism leads by the 
reduction of one molecule of atmospheric oxygen to water, followed by a one electron oxidation of 
the substrate [15]. As a consequence of this oxidation an oxygen-centered free radical is produced, 
which is generally unstable and more likely to undergo a second enzymatic catalysis reaction to be 
converted into a quinone molecule [15, 6]. In the laccase catalytic mechanism there are three key steps 
that have been identified which are as follows [2]: 
(i) Copper of first type (T1) is reduced by the substrate,  
(ii) Electron transfer from T1 copper site to the tri-nuclear site (T2&T3), and 
(iii) Reduction of molecular oxygen by the tri-nuclear centre. 
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The electron transfer from the substrate to the tri-nuclear cluster is carried out at the T1 copper site 
which is a distance of about 13Å from the tri-nuclear cluster. The laccase catalytic mechanism occurs 
at the copper sites, where atmospheric oxygen molecule is reduced into water through a four-electron 
reduction process [2].  When the completely reduced tri-nuclear cluster (T2&T3) interacts with 
molecular oxygen two intermediates are formed; which are identified as peroxide intermediate and 
native intermediate. The peroxide intermediate is formed through a 2e- process from the interaction of 
molecular oxygen with the reduced tri-nuclear cluster. A native intermediate is formed when the 
peroxide intermediate undergoes a second 2e- process and raptures into the native intermediate. The 
latter is believed to serve a significant purpose in the catalytic cycle of the enzyme by acting as oxygen 
radical throughout the reaction with molecular oxygen [2, 16].  
1.5. Laccase Mediator systems 
Laccases have a broad spectrum of substrate specificity and they play an important biological function 
in the biodegradation of lignin; however these green catalysts appear to possess a lower redox potential 
compared to other lignin degrading ligninolytic fungi (ligninolytic peroxidases) and therefore their 
oxidation capabilities are restricted to phenolic related compounds [17]. This implies that other non-
phenolic substrates possessing a higher redox potential cannot be oxidized by these enzymes.   
Nevertheless when the enzyme is applied together with what is called a laccase-mediator; one can 
overcome this obstacle and increase the oxidation aptitude of the enzyme; leading to the oxidation of 
nonphenolic lignin moiety substrates [3, 17]. Using laccases in the presence of a low molecular weight 
compound as redox mediators can potentially expand the substrate specificity of the enzyme and 
enhance its redox capacity towards obstinately uncooperative compounds. High molecular weight and 
bulky compounds such as lignin polymers usually don’t interact effectively with the laccase’s active site 
due to steric hindrance. Therefore the redox mediator plays a role of shuttling electrons; providing the 
oxidation of more complex compounds [17]. The idea behind using mediator systems was to utilise 
low molecular weight compounds that, when oxidised by the enzyme, can generate stable radical 
species and diffuse out of the enzymatic pocket allowing the enzyme to oxidize the high oxidation 
target compound without deactivating the enzyme itself [3]. Laccase mediator systems also turn out to 
be economical and environmentally friendly; hence they are utilized in environmental and industrial 
  6 
applications where they are used in the oxidation of aromatic methyl groups, bleaching of textile dyes, 
oxidation of benzyl alcohols and polycyclic aromatic compounds [3, 17]. 
1.6. Applications of  Laccases in Industries  
There is a continuous growing chain of research for the use of laccases for various industrial 
applications [9]. Laccases have been applied in numerous applications such as paint, furniture, food, 
pulp and paper, textile, cosmetic, biofuel, and nanobiotechnology related industries [2, 9]. 
1.6.1. Paint Industry 
The frequently used binding agents in the paints and coatings industry are polyester compounds 
consisting of unsaturated fatty acids known as alkyd resins [18]. Alkyd resins are usually prepared 
through a polymerization reaction of polyalcohols, dicarboxylic acids or anhydrides and unsaturated 
fatty acids and chemically dried through cross-linking of the unsaturated fatty acid scaffold catalysed by 
transition metal inorganic complexes [9, 18]. In search for efficient, less toxic and environmental 
friendly alternative catalysts, laccase-mediated systems were used to cross-link the alkyd resins as a 
replacement for transition metal catalysts [18].  
1.6.2. Furniture Industry  
In the furniture industry, laccases-mediated systems have been used in the production process of 
medium-density fibreboards (MDF) [9]. Traditionally MDFs are prepared by cross-linking 
lignocellulosic fibres melded with a synthetic resin in the presence of moisture under high 
temperatures and pressure [9, 19]. Formaldehyde is conventionally used as a binding agent for gluing 
lignocellulosic products; however for ecological and economic reasons alternative binding agents such 
as laccase-mediated systems have been employed for activating lignin on the fibre surfaces of wood 
during the pilot-scale production of MDF in a dry process [9, 20]. The boards produced using laccase 
mediated systems had comparable mechanical properties to the conventional methods and met all 
expected European standards for wood-based panels [20]. 
1.6.3. Food Industry  
In the food industry laccases are utilized because of their ability to promote both homo- and hetero-
polymerisation processes [9]. They are mainly used for stabilisation of wine and beer, fruit juice 
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processing, betterment of quality of various drinks, modifying colours of food or beverages, baking, 
deoxygenation of perishable oil products, and waste water treatment [2, 9]. Wines, beers, and fruit 
juices contain a high concentration of phenolic compounds; laccases can be used to measure the 
amount of phenolic compounds present in the drinks in the form of biosensor [2]. A number of 
laccase based biosensors have been developed to detect the presence of polyphenols in drinks such 
as tea and wine [21, 22]. On the other hand, commercial laccase Suberase® from Novozymes has 
been utilized in the wine industry for cleaning and polymerization of phenols (2,4,6-trichloroanisole) 
found in cork stoppers in bottled wine; as these compounds are known to add an unpleasant flavour 
to the wine giving it a bitter taste [2]. In the baking industry, laccase can be used to control 
rheological properties of dough; white-rot fungus laccase Trametes hirsuta was used to increase 
resistance of dough and reduced dough extensibility in flour and gluten dough through cross-linking 
of esterified ferulic acid on arabinoxylan fraction of dough [2, 23]. Laccases are also applied in 
bioremediation processes for waste water treatment [2]. Various laccases have been used for the 
removal of phenols in waste-water; this include: laccase from Cerrenaunicolor used for treatment of 
olive mill wastewater (OMW) in the oil industry [24], fungal laccase (Trametes pubescens) phenolic 
compounds and colour for the treatment of distillery wastewater from fermentation of sugarcane 
molasses for the production of ethanol [2].  
1.6.4. Pulp and Paper Industry 
In the pulp and paper industry, separating lignin from wood pulp is a very important process [2, 9]. 
The conventional way of doing it is through what is known as the “bleaching” process; which 
involves the use of chlorine-containing reagents which are harmful to the environment [2, 25]. 
Because laccases have been described as one of the enzymes responsible for wood decay by white 
rot fungi in nature; therefore they can be applied in delignification of wood fibre processes in the 
pulp and paper industry [2]. Applications of laccase-mediator-systems (Lignozym®-process) was 
described as an effective method to delignify wood in pulp and paper processes using mediators 
containing groups such as NO, NOH or HRNOH [26]. Laccase from Pycnoporus cinnabarinus was 
used along with various natural mediators (phenols syringaldehyde, p-coumaric acid, and 
acetosyringone) to bleach flax fibres [27]. 
  8 
1.6.5. Textile Industry 
Laccases have been shown to have a large and increasing variety of applications in the textile 
industry ranging from decolourization of dyeing effluent to bleaching of denims [28, 29]. The ability 
of laccase to oxidize a variety of phenolic and non-phenolic aromatic organic compounds can be 
utilized to promote homo and/or hetero-coupling reactions producing a range of characteristic 
colours for different valuable dyes for textiles [9, 30]. Laccases catalysed the oxidative coupling 
reaction of colourless 1,2-dihydroxybenzene and 2,5-diaminobenzenesulfonic acid to generate a 
polymeric dye, which was then used to dye cotton fabrics [30]. CotA laccase from Bacillus subtilis was 
used to catalyse the oxidative dimerization of ortho, meta, and para-disubstituted aromatic amines to 
yield substituted phenazine and phenoxazinone dyes [31]. An enzymatic method for grafting water 
insoluble phenolic compounds such as lauryl gallate found on wool fabric was developed using 
laccase as a biocatalyst [32]. 
1.6.6. Cosmetic Industry 
In the cosmetic industry laccases are being explored in personal care products for both skin and hair 
products [2, 9]. However, they are mainly used as oxidants and bleaching agents for hair; as a 
replacement for hydrogen peroxide [2, 33]. Compared to peroxide hair dyes, laccase-based dyes are 
preferable as they are less harsh and also easy to handle [2, 34]. There are also reports on laccases being 
applied in dermatological products containing proteins for skin lightening [2, 9]. 
1.6.7. Biofuel Industry 
Natural, abundant and renewable resources such as lignocellulosic biomass are one of the important 
feedstocks for the production of bioethanol [9].  Bioethanol is composed of carbohydrate polymers 
and an aromatic polymer (lignin), and in order to utilise it, lignin must be removed to expose sugars to 
efficiently hydrolyse the polysaccharides [35]. Laccase is one of the biocatalysts investigated for its 
application mainly as a delignifying agent in biofuel production, and also as a tool for removal of 
fermentation inhibitors (mainly phenolic compounds) that may arise from subsequent enzymatic 
processes [2, 35]. A laccase from T. versicolor was used for detoxification of lignocellulose to effectively 
remove phenolic compounds for the production of bioethanol [2, 36]. A recent study presented 
laccases from Ganoderma lucidum as a great tool for processing of lignocellulose for bioethanol 
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production. This laccase was able to remove up to 84% of phenolic compounds present in corn stover 
hydrolysate, and when added prior the cellulase hydrolysis step, ethanol productions were improved by 
10% [37]. 
1.7. Laccases in organic synthesis 
Laccases have proven useful in Green Chemistry as biocatalysts for organic transformations in a 
variety of bond formation reactions (C-C, C-O, C-N, and C-S) under mild and environmentally benign 
reaction conditions [2, 8]. Ranging from detoxification of phenolic pollutants, the transformation of 
antibiotics, to the dimerization of steroid hormone 17β-estradiol; laccases have been used to synthesize 
stable complex pharmaceutical products [2, 38]. 
1.7.1. Oxidative decomposition 
White rot fungus, Trametes sp. in a medium containing glucose and ethanol under aerobic conditions 
was used to convert ferulic acid into coniferyl alcohol [39]. The oxidative decomposition of ferulic 
acid in those conditions yielded other products along with coniferyl alcohol such as dihydroconiferyl 
alcohol, coniferylaldehyde, vanillyl alcohol, vanillic acid, 2-methoxyhydroquinone and 2-
methoxyquinone [2, 39]. Years later another oxidative metabolism of ferulic acid was reported, 
where laccase from white-rot fungus Pycnoporus cinnabarinus I-937 was used to transform  ferulic acid 
into vanillin (Scheme 1) [2, 40].  
 
Scheme 1: A biotransformation of ferulic acid by laccase [2] 
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1.7.2. Dimerisation and Trimerisation (C-C bond formation) 
All organic molecules consist of a carbon-carbon bond skeleton; consequently the understanding of 
carbon-carbon bond formation reactions is a key step in synthetic organic chemistry. Only a few 
biocatalysis routes have been accounted for in literature for the synthesis of C-C bonds [40]. However 
there are a few reports on laccase enzymes utilized as biocatalysts for C-C bond formation reactions. 
Examples of novel C-C bond formation reactions include intermolecular Diels-alder reactions between 
dienes and quinones to form o- and p-naphthaquinones catalysed by laccase from Trametes villosa; the 
reactions were conducted at 70°C, 3°C and room temperature in an open vessel using an acetate 
buffer (pH 4.5) (Scheme 2)  [41].  Laccase-catalysed oxidative dimerization (C-C coupling) of salicylic 
esters under aerobic conditions at room temperature was also achieved (Scheme 3) [42]. 
 
                   Scheme 2: Laccase catalysed synthesis of naphthaquinones Diel-Alder reactions [2] 
     
 
                                Scheme 3: Laccase catalysed self-coupling reactions of salicylic ester [42]  
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Another report shows the synthesis of dispiropyrimidinone derivatives via domino reactions catalysed 
by laccase from A. bisporus using a phosphate buffer (pH 6) at room temperature and the yields 
obtained were between 77% and 90% [43]. A number of functionalised biaryls have been synthesised 
through laccase-catalysed self-coupling reactions such as the biotransformation of 5,6,7,8-
tetrahydronaphthalen-2-ol were the effect of organic solvents on product formation was investigated 
using various aromatic solvents such as benzene and toluene [44]. Another laccase-catalysed C-C bond 
formation dimerization reaction was reported on a self-coupling reaction of bisphenol; the reaction 
was conducted in a phosphate buffer (pH 6) at room temperature using laccase from T. villosa 
(Scheme 4) [45].  
 
             Scheme 4: Laccase-catalysed self-coupling reaction of bisphenol [46] 
Depending on the type of substrate, solvent or co-solvent used, and also the type of laccase source; 
formation of dimeric and/or trimeric products is highly affected [46]. Tranchimand et al. (2006) 
reported the effectiveness of using biphasic solvent systems during the laccase catalysed bio-
transformation to form liganans from ferulic acids and sinapinic acids [47]. The products obtained 
from biphasic systems were more stable and in greater yields and they were easy to separate with good 
product selectivity [46, 47]. Other studies show the influence of the type of laccase source on the 
formation and ratio of dimer products; where two laccases, (Pycnoporus coccineus (fungus) and Rhus 
vernicifera Stokes (tree)) were used in the biocatalytic oxidation of isoeugenol and coniferyl alcohol. The 
reactions were conducted in acetone-water system and it was found that the oxidation of the substrates 
by P. coccineus laccase was faster than that of the R. vernicifera Stokes laccase [46, 48]. Another report on 
the influence of laccase source towards yield of reaction products was on the dimerization 3,5,4’-
trihydroxystilbene catalysed by laccases from Myceliophtora thermophyla and Trametes pubescens in n-BuOH 
saturated with phosphate buffer (pH 6.5) [49]. The product yield obtained using M. thermophyla laccase 
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(Scheme 5) was significantly higher (31%) than that obtained from the oxidation by the T. pubescens 
laccase (18% yield) [2, 49]. 
 
                  Scheme 5: Laccase-catalysed dimerization of 3,5,4’-trihydroxystilbene [46] 
There is a number of studies reported in the literature that have investigated how laccase mediators 
play a role in laccase reactivity in organic synthesis and it was demonstrated that they can improve 
reaction yields and selectivity [46]. Ganachaud et al. (2008) demonstrated this effect while investigating 
the laccase-catalysed trimerisation of indole to afford 2,2-bis(3′-indolyl)indoxyl as one the products 
[50]. The mediators explored were ABTS, TEMPO, and HBT and it was found that TEMPO was the 
most efficient; reducing reaction times from 48 to 24 h and improved the yield from 23% to 51% [46, 
50]. 
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1.7.3. Nuclear amination (C-N bond formation) 
Laccases in amination reactions are becoming one of the most important synthetic routes to complex 
organic molecules. The use of these enzymes to catalyse C-N bond cross-coupling reactions represents 
an effective procedure for the synthesis of significant and important (C-N) biological molecules in 
mild reaction conditions [51]. There have been various novel examples of laccase-catalysed amination 
reactions reported in literature and amongst the products synthesised are novel antibiotics [51, 52]. 
Since 2005 the synthesis and development of aminoquinone molecules has been studied using fungal 
laccases [2]. Depending on reaction conditions such as molar ratio of substrates, solvents and co-
solvents, type of buffer system used, concentration of laccase, reaction time, temperature, and pH of 
solution; the formation of mono- or di-aminobenzoquinones products was extremely influenced. It 
has been reported that different laccases tend to show different reaction courses and good to very 
good yields of aminoquinone products can be obtained using alkylated quinones and primary aromatic 
amines [53]. Niedermeyer et al. (2005), conducted a study on the formation of mono-aminated and di-
aminated benzoquinones using two fungal laccases, and one of the findings was that one of the 
laccases favoured the formation of mono- over di-aminated products where else the other formed 
more di-aminated over mono-aminated products in various reaction conditions (Scheme 6) [2, 53]. 
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       Scheme 6: (a) Monoamination (b) Diamination (c) Mono- and di-amination of p-hydroquinone catalysed by laccase [2] 
In 2007 there was another study on laccase ability to initiate nuclear amination of para-hydroquinones 
with primary amines using laccase from Myceliophthora thermophila and laccase C from Trametes sp. for the 
formation of monoaminated and diaminated quinone products (Scheme 7) [2, 54]. Another study on 
nuclear deamination on p-hydroquinones with aliphatic and aromatic amine substrates was conducted 
using commercial laccase Denilite® II base from Novozymes. The reactions were done at room 
temperature and at 35 °C in the presence of an immobilized laccase, succinate-laccase buffer (pH 4.5), 
and a co-solvent to afford aminated p-benzoquinone products. It was observed that regardless of the 
reaction conditions, the reactions favoured the formation of diaminated products over monoaminated 
products but the products obtained were in very low yields (Scheme 8) [2, 55]. 
 
Scheme 7: Monoamination of p-hydroquinone with primary amine catalysed by laccase [2] 
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             Scheme 8: Diamination of p-hydroquinone with primary amine catalysed by laccase [2] 
1.7.4. Oxidative Coupling (C-O bond formation) 
Fungal laccases have been used to catalyse carbon-oxygen bond formation through C-O bond cross-
coupling reactions of dihydroxylated aromatic substrates with aliphatic alcohols under mild reaction 
conditions. It has been proven that fungal laccase can catalyse the cross coupling reaction between 
methanol and other alcohols with dihydroxylated aromatic compounds [56]. A fungal laccase from T. 
villosa obtained from Novo Nordisk (Bagsvaerd, Denmark) was used to catalyse the cross-coupling 
reaction of dihydroxylated aromatic substrates with alcohols in an acetate buffer (pH 5) to form 
homomolecular and heteromolecular products (Scheme 9) [2, 56].  
 
                                     Scheme 9: Laccase-catalysed C-O bond cross-coupling reaction [2] 
However oxidative coupling of phenolic substrates carried out in the presence of a solvent, an alcohol 
or in aqueous solution may afford a couple of undesired side reactions as these reactions tend to form 
homo-molecular hybrid molecules such as dimers and trimers and also the fact that aromatic and 
aliphatic alcohols can be candidates of laccase catalysis [56, 57]. As a result of the formation of homo-
molecular products during the synthesis processes of these cross-coupling reactions the yields obtained 
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for the desired heteromolecular products are affected to a large extent [56]. This is evident that there is 
a need to develop optimal conditions for these reactions in order to minimize the formation of side 
products such as homomolecular products as well as the occurrence of heteromolecular coupling 
between solvent systems and laccase substrates leading to undesired product formation. 
1.7.5. Thio-bond formation (C-S bond formation) 
At this point in time, there is a limited number of reports in literature on the laccase-catalysed C-S 
bond formation reactions [2]. Although these compounds possess a number of biochemical and 
biotechnological benefits, the amount of research towards this kind of synthesis has not been 
addressed to a greater extent. Regardless of the extent of research; a couple of researchers have 
reported on a number of synthesis of C-S bond formation reactions, these include the laccase-
catalysed reaction of p-hydroquinones with aromatic thiols through 1,4-Michael addition reaction to 
form multiple C-S bonds in variable reaction conditions and it was discovered that laccases are 
convenient catalysts for the formation of heteromolecular thiolated products at environmentally 
favourable conditions (Scheme 10) [58]. Another study was conducted on one-pot laccase synthesis of 
1,4-naphthoquinone-2,3-bis-sulfides using aryl and alkyl thiols at different pH values and it was found 
that the yields of the product were highly affected by pH of solution, solubility of substrates, 
nucleophilicity, and mole ratio of thiol to laccase substrate. Another factor causing low yields of 
products was laccase inhibition by thiols, therefore development of laccases which are resistant to thiol 
inhibition is a novel way to improve C-S bond formation reactions [59]. 
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Scheme 10: Laccase catalysed C-S bond formation reaction [2] 
Substances such as ionic liquids (ILs) have been investigated as alternative solvents or co-solvents for 
biocatalytic reactions of many enzymes including laccases [60]. Three types of water soluble ILs (1-
ethyl-3-methylimidazolium 2-(methoxyethoxy) ethylsulfate, 1-ethyl-3-methylimidazolium 
methanesulfonate, and1-ethyl-3-methylimidazolium ethylsulfate) have been used to investigate the 
activity and stability of the commercially available laccase Denilite® II base at various pH levels, and 
they were found to show good stability of the enzyme and also were able to inhibit enzyme activity 
loss for a period of 7 days [61]. On another report it was shown that ILs can be an alternative solution 
for solubility problems encountered during laccase biocatalysis involving poorly water soluble 
substrates [62]. 
 
 
  18 
1.8. Benzoxazoles 
 
Figure 2: Benzoxazole 
Benzoxazoles are important heterocyclic organic compounds consisting of a benzene-fused oxazole 
ring structure (Figure 2). They are frequently encountered as structural units in natural products and 
are often used as starting material for synthesis of larger pharmaceutical drugs and organic molecules 
[63]. The benzoxazole scaffold is found in many significant chemotherapeutic and biologically active 
compounds and they are widely used in medicinal applications [64]. Due their potent biological 
properties, benzoxazoles have received great attention in chemistry and biochemistry [65]. Various 
examples of medicinal application include: amyloidogenesis inhibitors [66], estrogen receptor-b 
agonists [67], Human GSTP1-1 inhibitors [68], melatonin receptor agonists [69], anti-HIV-1, 
anticancer, antimicrobial agents [70], anti-tuberculosis agents [71], anti-bacterial [72], anti-fungal [73], 
Rho kinase inhibitors (Figure 3) [74]. 
 
Figure 3: Examples of pharmaceutical important benzoxazoles [3, 9] 
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Furthermore, they also possess numerous industrial applications; some of them have been utilized in 
fluorescent sensors for application in two-photon microscopy [75]. Substitution around the 
benzoxazole nucleus results in luminescent characteristics; were they can be used in organic light 
emitting diodes (OLEDs) as fluorescent whitening agent dyes [65]. In addition benzoxazoles have 
been utilized as dye releasers in instant colour chromatography [76], dye lasers [77], as ligands in 
asymmetric synthesis [78] and polymer synthesis [79] (Figure 4). 
 
                     Figure 4: Compounds bearing benzoxazole nucleus  
There are various methods reported for the synthesis of benzoxazoles; these include 2-aminophenol 
with carboxylic acids and their derivatives (amines, alcohols, acyl halides, and nitriles) catalysed by 
strong acids or microwave conditions. Another involves cyclization of Schiff bases derived 
condensation–dehydration reaction of 2-aminophenol with aldehydes in the presence of an oxidizing 
agent; oxidants include ThClO4, Pb(OAc)4, Mn(OAc)3, DDQ, PCC-supported silica gel,  Dess-Martin 
reagent, NiO2, and many more [80]. Other methods include cyclisation of 2-halo-N-acylanilines, 
reaction of 2-aminophenol with carbon–carbon triple bonds, or reaction of bromoaniline with acyl 
halides [65, 81]. However there are many setbacks associated with the majority of the reported 
methods for the synthesis of benzoxazoles. These include the use of toxic and expensive reagents, 
harmful organic solvents, high reaction temperatures, longer reaction times, and tedious work-up 
procedures [80].   
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1.9. Benzimidazoles 
 
Figure 5: Benzimidazole 
Benzimidazoles are a class of heterocyclic aromatic compounds composed of a phenyl ring fused with 
an imidazole ring system (Figure 5). One of the prominent natural occurring derivatives of 
benzimidazoles is N-ribosyl-dimethyl benzimidazole; a component of inhibitors such as factor Xa 
(Fxa) inhibitors, poly (ADP-ribose) polymerase (PARP) inhibitors, 5-HT3 antagonists, and 5-
lipoxygenase inhibitors, and also serves as one of the cobalt ligands in vitamin B12 [82]. 
Benzimidazoles consisting of different substituent(s) around their core are associated with a wide range 
of biological and pharmacological activities such as anti-tumour, anti-ulcer, anti-fungal, anti-
hypersensitive, anti-rhino, anti-allergic properties, as well as neuropeptide Y Y1 receptor antagonists 
[83, 84]. Furthermore, through blocking the secretion of gastric acid in the stomach, substituted 
benzimidazoles can act as gastric H+ /K+ ATPase inhibitors [85]. 
Because of their remarkable biological activities, benzimidazoles have been studied for more than a 
century, and amongst other important heteroaromatic compounds, they possess a scaffold essential in 
many natural products and can be found in several well recognized pharmaceutical drugs [86, 87]. 
Some of the well-known available drugs bearing a benzimidazole scaffold include albendazole, 
mebendazole, omeprazole, and bendamustine (Figure 6) [88]. Furthermore, compounds with 
benzimidazole moieties have been utilized in material science applications; they are often used as 
membranes for fuel cells and also in organic light-emitting diodes [89].  In this regard, synthetic 
procedures directed towards the synthesis of compounds containing the benzimidazole core have 
become a subject of interest, and various methods for the synthesis of these heterocycles are being 
formulated [83, 88]. 
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Figure 6: Examples of biological active benzimidazole derivatives [88] 
 
The classical methods for the synthesis of benzimidazoles involve condensation reactions of 1,2-
phenylenediamines with carboxylic acids and their derivatives in the presence of strong acids, ionic 
liquids, nanomaterials and zeolites [88, 90]. Another is oxidative cyclisation of Schiff bases obtained 
from condensation reactions between 1,2-phenylenediamines and aromatic aldehydes [88, 89].  A 
number of oxidants have been used in the synthesis of benzimidazoles and their derivatives, including 
iodine, peroxides, 1,4-benzoquinone, nitrobenzene, cupric acetate, and (bromodimethyl)sulfonium 
bromide, and  recent advances include procedures such as microwave assisted synthesis, solid phase 
synthesis and enzyme catalysts [83, 86]. However, most of the available methods are at a disadvantage 
because they make use of harsh reaction conditions such as high temperatures and organic solvents, 
and some require the use of toxic reagents [83, 91]. The major drawback with the synthesis of 
benzimidazoles is the chemo-selectivity during the reaction process; they usually end up with the 
formation of a mixture of two products (2-substituted and 1,2-disubstituted benzimidazoles) [90]. 
In this sense, various methodologies have been formulated to work around the chemo-selectivity issue 
to selectively form either 2-substituted or 1,2-disubstituted benzimidazoles [90]. Chari et al. (2011) 
demonstrated the importance of the presence of oxygen in the system for these reactions to occur and 
also showed that the presence of an oxidizing agent promotes selectivity towards the formation of the 
mono-substituted benzimidazoles [92]. Fan et al. (2015) developed a highly chemo-selective method to 
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obtain different substituted benzimidazoles under mild reaction conditions [90]. In 2011, an enzymatic 
catalysed reaction to afford benzimidazole derivatives was reported; where laccase from Agaricus 
bisporus was used to catalyse the condensation reactions of o-phenylenediamine and various aldehydes 
to obtain 2-substituted benzimidazoles [82]. The reactions were performed using phosphate and 
acetate buffers as solvent systems, but due to solubility issues of organic substrates, methanol was used 
as a co-solvent to yield substituted 2-aryl-1H-benzimindazoles. However, under these reaction 
conditions, selectivity was still an issue; the reactions led to formation of the di-substituted side 
product (compound 4) (Figure 7). Reaction conditions were varied to aid selectivity towards 
formation of mono-substituted benzimidazoles by changing the ratio of buffer to solvent. But this did 
not result in significant improvement, compound 4 was still formed and other side products as well 
[82]. 
 
 
Figure 7: 1-benzylated benzimidazole 
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1.10. Benzothiazoles 
 
Figure 8: Benzothiazole 
Benzothiazoles are an important class of bicyclic aromatic heterocyclic compounds composed of a 
benzene ring fused to a thiazole ring system, where a thiazole ring is a five membered ring made up of 
one sulphur and one nitrogen in the ring  (Figure 8) [93, 94]. The heterocyclic scaffold of 
benzothiazoles can be readily substituted with various functional groups and it is known to possess 
incredible pharmacological and therapeutic properties.  They have found numerous applications in 
medicinal chemistry as antitumor, anticancer, anti-HIV, antiviral, antimicrobial, antibacterial, 
anthelmintic, and anti-diabetic, anti-allergic, and anti-inflammatory agents [93-99]. Compounds bearing 
the benzothiazole nucleus have been presented in a number of applications; during the 1950s, 
compounds with the 2-aminobenzothiazole scaffold were intensively investigated; some displaying 
activity against cancer cells and they were also utilized in biochemical and electrophysiological 
applications [93, 94]. 
 
Scheme 11: Laccase-catalysed reaction of 2-aminothiophenol with aryl-aldehydes 
Other applications include use as a LTD4 antagonist, an orexin receptor antagonist, a stearoyl-
coenzyme A δ-9 desaturase (SCD) inhibitor and use in industry as oxidants, industrial dyes, functional 
materials. Furthermore it is also used for imaging of amyloid plaques, and its an analogue for firefly 
luciferase responsible for light-emission (Figure 9) [96-104].    
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    Figure 9: Examples of important benzothiazole compounds 
Due to their substantial biological activity, developments of efficient synthesis methods for 
benzothiazoles compounds have received a significant amount of interest [93]. There are many 
methods already in place for preparing benzothiazole derivatives; the conversional methods include 
condensation–dehydration reaction of 2-aminothiophenol with carboxylic acids and their derivatives 
under strong acid and high temperature conditions or condensation with aldehydes under oxidative 
conditions (Scheme 11) [95, 96]. Transition-metal catalysed cross-coupling reactions of benzothiazoles 
and aromatic halides using aromatic boronic and carboxylic acids [97]. Even though these methods are 
quite efficient, they still display a number of disadvantages; these include the use of toxic oxidants, 
abrasive reaction conditions (high temperatures, pressure and longer reaction times), use of expensive 
transition metals and strong acids, and also use of environmentally unfriendly solvents [96, 97].  With a 
growing demand for green chemistry, the preparation of 2-aryl-benzothiazoles using environmental 
benign processes such as transition-metal free reactions, ambient reaction conditions, use of 
biocatalysts and green solvents is of paramount importance. 
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AIMS AND OBJECTIVES 
The overall aim of this research project was to investigate the range and limitations of applications of 
laccase enzymes in organic synthesis. The project concentrates on method development and 
improvement of reaction conditions for the catalysis of bond formation in organic reactions such as 
oxidation, amination, and oligomerization under moderate and environmentally friendly conditions. 
The primary focus of this study was on the catalysis of bond formation (C-C, C-O, C-N, and C-S 
bonds); specifically on cross-coupling reactions of Nitrogen, Oxygen, and Sulphur based aromatic 
compounds. The final part of the project seeks to determine the limiting factor in the resultant yields 
by varying the reaction conditions.  
The project consists of five sections which are the synthesis of biaryl compounds, benzoxazoles, 
benzimidazoles, benzothiazoles, and aminobenzoquinones. Use of laccases to synthesise biaryl bonds 
from substituted phenol substrates at room temperature using different organic solvents was 
investigated. We explore the use of laccase to catalyse both self-coupling and cross-coupling reactions 
of simple phenols as we identify optimal reaction conditions for these reactions. For benzoxazole 
derivatives we aimed at developing an effective method to catalyse the synthesis of 2-aryl-benzoxazole 
derivatives using laccase at room temperature; looking at factors such as solvents effects, influence of 
laccase origin and also the use of laccase-mediator systems. For benzimidazole derivatives we 
investigated the effect of different solvents or co-solvents towards the selectivity of these reactions. 
We also conducted a control study in different solvents/or co-solvents to determine what role does 
the enzyme play in these reactions. We describe how different enzymes affect the outcome of the 
reaction with various benzaldehydes, as we identify the optimal conditions for these reactions. For 
benzothiazole derivatives, while exploring the above mentioned factors, we developed a modern and 
practical laccase-catalysed route for the synthesis of 2-arylbenzothiazoles. To the best of our 
knowledge, the laccase-catalysed method for preparation of 2-arylbenzothiazole derivatives from 
condensation–dehydration reaction of 2-aminothiophenol with aryl-aldehydes has not been reported 
before. The method described is green, effective and simply requires an easy work-up routine, utilizing 
solvents such as acetonitrile and DMF as co-solvents. 
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For the final section of this study we investigated improvement of yields of the monoaminated and 
diaminated products during amination reactions. The laccase-catalysed nuclear diamination of aromatic 
hydrobenzoquinones with aliphatic and aromatic amine molecules was investigated at mild reaction 
conditions using commercial laccases from Novozymes (Suberase®, Denilite® II Base, and 
Novoprime Base 268). Other factors that impact on reaction yield were explored; these include 
conducting reactions under dilute conditions, sequential addition of enzyme and substrate over time, 
and also the effect of buffer and co-solvents.  
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C h a p t e r  2  
RESULTS AND DISCUSSION 
2.1. Dimerization of phenols 
In literature, the laccase catalysed formation of biaryl compounds has been demonstrated for a variety 
of molecules.  Examples of laccase-catalysed self-coupling reactions such as the biotransformation of 
5,6,7,8-tetrahydronaphthalen-2-ol, synthesis of dispiropyrimidinone and self-coupling reaction of 
bisphenol have been reported [43-45]. Most of the studies in this area have been carried out on large 
compounds; therefore our aim was to apply the same principles using simple phenolic substrates to 
accomplish similar results. Various phenolic substrates were subjected to different commercial laccases 
from Novozymes (Suberase®, Denilite® II Base, and Novoprime Base 268) to catalyse the oxidative 
coupling reactions of phenols via radical mechanism to form biaryl bonds under aerobic conditions 
(Scheme 12).  
 
Scheme 12: Laccase-catalysed oxidative dimerization of phenols 
It is understood that self-coupling reactions of phenolic substrates via a radical mechanism are most 
likely to form oligomers and polymers [44, 45]. Polymerization of Bisphenol A was demonstrated 
using laccase from T. villosa (Scheme 4); some of the products obtained such as 5,5’-bis-[1-(4-
hydroxy-phenyl)-1-methyl-ethyl]-biphenyl-2,2’-diol and some oligomers were insoluble and were 
revealed by Field-desorption mass spectrum analysis [45]. In one report the effect of different organic 
solvents on product formation was investigated, where relative ratio of the dimers found was 
significantly influenced by the nature of organic solvent used and the general yields of the dimers 
found were quiet low [44]. On this basis, the reactions were conducted in different solvents and/or co-
solvent systems at various temperatures to account for solvent effects, using solvents such as 
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acetonitrile, methanol, toluene, DCM, and DMF and various substitutions around the phenolic 
substrates were used to limit the rate of polymerization.  
Our first attempt was to perform self-coupling reactions by carrying out laccase-catalysed oxidations 
on a series of substituted phenol derivatives. We hypothesised that laccase primarily oxidises the 
phenolic moiety of the substrate, thereby generating phenoxy radicals; from these radicals, cross-
coupling reactions may take place to produce biaryl bonds. Various substituted phenolic substrates 
(Figure 10) were dissolved in acetate buffer (10.0 mL, 0.1 M, pH 4.50) and DMF (10.0 mL) and were 
subjected to commercial laccase Suberase® from Novozymes at room temperature. The reactions 
were conducted for a period of 72 h under aerobic conditions and were monitored by TLC. In all 
attempts, no activity was observed except for 4-bromophenol and 2,4-dichlorophenol, however the 
products were not characterised because they were insoluble. For 4-bromophenol and 2,4-
dichlorophenol, it was anticipated that since the reaction occurs through the generation of phenoxy 
radicals; the cross-linking reactions might have led to polymerization. However due to solubility issues, 
the products were not characterised. Intra et al. (2005) demonstrated the significant influence of 
solvents effect on the selectivity of laccase-catalysed oxidation of phenols [44]. On this basis, we 
conducted self-coupling reactions using different solvents such as methanol, toluene, acetonitrile, and 
DCM but no activity was observed for most of the substrates. Using toluene as a co-solvent, some 
activity was observed for 4-nitrophenol and 2,4-dichlorophenol, however, the reactions reversed 
during work-up (Table 1). 
 
Figure 10: The phenolic substrates used in this study 
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Table 1: Laccase-catalysed phenol coupling reactions in toluene 
Entry Phenol I Product Yield 
 
1 
 
 
 
Not 
determineda 
 
2 
  
 
0 
 
3 
 
 
 
Not 
determinedb 
 
4 
 
 
 
Not 
determineda 
 
5 
 
 
 
0 
 
6 
 
 
 
0 
 
7 
 
 
 
 
0 
a- Product was not characterised due to solubility issues. 
b- Activity observed but reaction reversed during work-up 
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The results suggests that for the majority of the substrates the enzyme was unable to initiate the 
oxidation of the phenolic moiety to generate phenoxy radicals (Ph-O•). Similar results were observed 
with different organic solvents and other laccases. For the substrates that showed activity, major 
hurdles such as solubility issues and reversibility of the reaction still need to be addressed.  
Our second attempt was to investigate cross-coupling reactions between various substituted phenol 
derivatives (Scheme 13). The aim here was to investigate if different functional groups have any 
significant influence on reactivity; thereby distinguishing if whether cross-coupling reactions between 
phenols have better reactivity compared to self-coupling reactions. The reactions were conducted 
using the same reaction conditions as in self-coupling reactions; however, no activity was observed for 
all the reactions. All of the tested substrates behaved the same, and the same results were obtained as 
in self-coupling reactions. At this stage, all the methods tested for the synthesis of biaryl compounds 
from phenolic substrates catalysed by laccase were not effective. Interesting results were obtained for 
self-coupling reactions of 4-bromophenol and 2,4-dichlorophenol, however the products were not 
characterized because of solubility issues. The overall difficulty encountered in these reactions is the 
initiation of the reaction through generation phenoxy radicals (Ph-O•) by the enzyme, and also the 
propensity of the reactions to favour the reverse reaction. The addition of more enzyme over time 
helped to overcome this; but generally it is still a major draw-back. The high loading of enzyme had no 
significant effect on either self-coupling or cross-coupling reactions; it seems that not enough radicals 
were generated to drive the reaction in the forward direction under the described reaction conditions.  
 
Scheme 13: Laccase-catalysed oxidative dimerization of phenols 
Based on the experimental data collected, it was suggested that the laccases used in this study may be 
unable to catalyse the oxidation of the phenolic substrates, i.e. their oxidation potency might be 
inadequate to generate phenoxy radicals (Ph-O•); therefore the use of mediators could help enhance 
the overall activity. The mediator plays a role of shuttling electrons; when oxidized by the enzyme it 
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can generate stable radical species which will in turn oxidise the substrate of interest [17]. Using ABTS 
as a mediator, various substrates were subjected to laccase in acetate buffer (0.1 M, pH 5.0) at room 
temperature under aerobic conditions (Scheme 14). 
 
Figure 11: Structure of ABTS  
Laccase Mediator self-coupling reactions 
 
Scheme 14: Oxidative dimerization of phenols using laccase-mediator systems 
Using ABTS as a mediator; the laccase-mediator dimerization of a series of substituted phenols was 
investigated. The reactions were carried out using acetate buffer (5.00 mL, pH 4.50), a co-solvent (5.00 
mL), Laccase (Novoprime Base 268 (80.0 mg)) and ABTS (2.00 mL) at room temperature. Activity 
was only observed for p-nitrophenol as determined by TLC; it appears there was some form of 
polymerisation occurring. As previously described, no form of activity was observed with most of the 
substrates tested. Overall, the optimal conditions for obtaining biaryl compounds using laccase were 
not accomplished. Cases of polymerisation were observed numerus times, however due to solubility 
issues the products were not characterised. On the basis of literature reports, it could be contended 
that the laccases used in this study did not possess enough oxidation potency to initiate the one 
electron oxidation of many of the presented phenols [43-45]. Where oxidation did occur, 
polymerisation proceeded, and the desired products were not formed. However, with further 
optimization of reaction conditions with different mediators in combination with other laccase 
enzymes, biaryl compounds may yet be obtained.  
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2.2. Synthesis of benzoxazole derivatives 
 
Scheme 15: Synthesis of benzoxazole derivatives 
As mentioned in Section 1.8 condensation–dehydration reaction of 2-aminophenol with aldehydes in 
the presence of an oxidizing agent is one of the most explored methods for preparing benzoxazoles. It 
is important to realise that enzymes have not yet been explored as alternative oxidants for the 
preparation of benzoxazoles from Schiff’s bases derived from condensation of 2-aminophenol with 
aldehydes. In this research, a laccase-catalysed synthetic method was investigated for catalysing the 
synthesis of 2-substituted benzoxazoles through condensation–dehydration reaction of 2-aminophenol 
and aromatic aldehydes under aerobic conditions (Scheme 15). Reaction of 2-aminophenol (10.0 
mmol, 1.08 g) with 2-Chlorobenzaldehyde (10.0 mmol, 1.41 g) was selected as the model reaction 
catalysed by commercial laccase, Suberase® from Novozymes at room temperature. The reaction was 
conducted in acetate buffer (0.1 M, pH 4.0) and a co-solvent (40%).  
 
Figure 12: 2-amino-3H-phenoxazin-3-one 
Sousa et al. (2014) reported a laccase-mediated method for dimerization of several ortho and meta, para-
disubstituted aromatic amines into phenazine and phenoxazinone derivatives. Taking this into account, 
it was anticipated that the reaction was likely to be accompanied by the occurrence of dimerization; 
where 2-aminophenol couples with itself to form 2-amino-3H-phenoxazin-3-one (dimer 4a) (Figure 
12). It is assumed that in the presence of a catalytic amount of laccase, the oxidative dimerization of 1a 
begins with the oxidation of 2-aminophenol (1a) to 6-iminocyclohexa-2,4-dienone (5), which reacts 
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with another molecule of 2-aminophenol (1a) through an inter- and an intramolecular 1,4-addition to 
yield 2-amino-10,10a-dihydro-3H-phenoxazin-3-one (6). The final step is another oxidation of 6 to 
yield 2-amino-3H-phenoxazin-3-one (4a) (Scheme 16). 
 
 Scheme 16: A laccase-catalysed aerobic dimerization of 1a to yield 2-amino-3H-phenoxazin-3-one 
For the model reaction no dimerization was observed under the described reaction conditions, 
however, the reaction intended did not go to completion. The formation of benzoxazole 3 is 
commonly understood to proceed in a sequence of steps: the first step is the condensation reaction of 
2-aminophenol derivatives (1) with aromatic aldehydes (2) to yield Schiff base 7. This is then followed 
by cyclization of 7 to yield a 2, 3-dihydrobenzoxazole derivative 8, which then undergoes oxidation to 
give the corresponding benzoxazole 3 (Scheme 17). Following the proposed reaction mechanism, the 
step between Schiff base 7 and benzoxazoline intermediate 8 did not take place. From TLC results, the 
disappearance of the substrates was completed after 2 h of reaction and the solid product obtained was 
purified by washing with cold acetonitrile. It was observed that the reaction proceeded with the 
proposed mechanism except that cyclisation of Schiff base 7a to generate 2-(2-chlorophenyl)-2,3-
dihydrobenzoxazole (8a) does not take place. The purified product 2-((2-
chlorobenzylidene)amino)phenol (7a) was characterized by IR, NMR (1H and 13C), and mass 
spectroscopy. As determined from proton NMR; a total of nine signals were observed in the aromatic 
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region. A singlet at 9.03 ppm was assigned to the alkene proton (H7’), a doublet at 8.09 ppm was 
assigned to H6’, a multiplet integrating four protons observed at 7.35 – 7.17 ppm was assigned to H3’, 
H4’, H5’, H3 protons; two triplets at 7.12 and 6.80 ppm were assigned to H5 and H4 respectively, and 
a doublet at 6.91 ppm was assigned to H6 proton (Figure 13). Elemental and mass spectra data also 
corresponds to the mass of Schiff base 7a; where the mass calculated for compound 7a C13H10ClNO: 
231.68, and the mass found: [M+H]: 232.05; confirming that cyclisation into a five membered ring did 
not take place.  
 
   Figure 13: Schiff base 7a 
 
          Scheme 17: Reaction of 2-aminophenol with benzaldehyde derivative to yield benzoxazoles 
 
It has been demonstrated before that for the preparation of benzoxazoles the type of solvent used 
plays an important role on the yield and rate of reaction [64]. Our second approach was to investigate 
the role of co-solvents as we identify optimal condition to achieve benzoxazole derivatives. The 
laccase-catalysed reaction of 2-aminophenol (10.0 mmol, 1.08 g) with benzaldehyde (10.0 mmol, 1.06 
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g) in acetate buffer (0.1 M, pH 4.0) was carried out using various solvents such as methanol, ethanol, 
dichloromethane, DMF and acetonitrile at room temperature. In all conditions, no dimerization of 2-
aminophenol was observed and it was discovered that the reaction proceeds at different rates along 
with yield using different co-solvents (Table 2). Acetonitrile (Table 2, entry 4) was found to be the 
best solvent for this transformation, using commercial laccase, Suberase® from Novozymes at room 
temperature. However, as before, the reaction did not go to completion; the cyclisation step from 7a 
to 8a did not occur and the product isolated was compound 7a. Patil et al. (2017) also identified 
acetonitrile as the best solvent for the synthesis of benzoxazoles while preparing 2-phenylbenzoxazole 
at 60 °C using 10 mol % of TiO2–ZrO2 catalyst.  
Table 2: Effects of co-solvent in the laccase-catalysed synthesis of 2-(2-chlorophenyl)benzoxazole (3a) 
Entry Solvent Time (h) Yield 3a (%) Yield 7a (%) 
1 Methanol 24 - 70 
2 Ethanol 12 - 76 
3 Dichloromethane 6 - 85 
4 Acetonitrile 0.5 - 94 
5 DMF 2 - 89 
 
Using acetonitrile as the optimal co-solvent, derivatives of 2-aminophenol were treated with a series of 
aromatic aldehydes under aerobic conditions using commercial laccase, Suberase® from Novozymes 
at room temperature and the obtained results are summarized in Table 3. All the experiments were 
carried out according to the general method described below varying both the 2-aminophenol and 
aromatic aldehyde derivatives at room temperature. Under the described experimental conditions, no 
sign of dimerization was observed and as before cyclisation of Schiff base 7 did not take place for any 
of the substrates tested. All the products were characterized using proton and carbon NMR and high 
  36 
resolution mass spectrometry, and key signals (1H and 13C NMR) for selected products are summarised 
in Tables 4 and 5. From proton NMR data; all the substrates showed the alkene proton singlet peak 
observed in a chemical shift range 8.54 – 9.16 ppm and most of the substrates showed the OH proton 
peak, although some did not due to solvent exchange. However the elemental and mass spectra data 
corresponds to the masses of the described products.  
A control study was conducted using the optimal conditions without the enzyme in the reaction vessel 
and the results were quite similar to the ones obtained with the enzyme. However, it was observed that 
in the presence of a catalytic amount of laccase the reaction times are shorter compared to the 
reactions conducted without the enzyme. It has been shown in literature that the aromatic aldehydes 
with different substituents such as –Cl, –Br and –OMe groups show different reactivity; where the 
electron-withdrawing groups are showing greater product yields and faster reaction rates compared to 
aldehydes containing electron-donating groups [80]. In our case, most of the substrates showed equal 
ease towards the formation of products with reasonable to excellent yields. Some of the substrates 
containing a –OMe group showed somewhat slow reaction rates, but overall, the yields and rates were 
comparable to other substrates. 
General method used to synthesize 2-aryl-benzoxazole derivatives 
A mixture of 2-aminophenol derivative (10.0 mmol) and benzaldehyde derivative (10.0 mmol) in 
acetonitrile (10.0 mL) and acetate buffer (0.1 M, 10.0 mL, pH 4.0) was stirred at room temperature for 
5 minutes. Suberase® (2.00 mL) was added into the mixture and the contents were stirred till 
completion (monitored by TLC). When the reaction completes, the product precipitates from the 
solution and was extracted with ethyl acetate (30.0 mL) and water (3 x 20.0 mL). After extraction, the 
product was concentrated under reduced pressure and washed several times with cold acetonitrile (3 x 
20.0 mL) to remove excess starting material. 
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Table 3: Reaction of 2-aminophenols (1a-b) with benzaldehydes 2a–t (1:1 ratio) in acetate buffer (pH 
4.0) and acetonitrile under air at room temperature 
Entry Aminophenol Aldehyde Product Yield 
(%) 
Time 
(h) 
 
1   
 
 
94 
 
0.5 
 
2  
  
 
87 
 
1 
 
3  
 
 
 
72 
 
3 
 
4  
 
 
 
96 
 
1 
 
5  
 
 
 
93 
 
1 
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Table 3: Reaction of 2-aminophenols (1a-b) with benzaldehydes 2a–t (1:1 ratio) in acetate buffer (pH 
4.0) and acetonitrile under air at room temperature 
 
6  
 
 
 
97a 
 
1 
 
7  
 
 
 
98 
 
1 
 
8  
  
 
76 
 
6 
 
9   
 
 
93 
 
2 
 
10  
 
 
 
62 
 
36 
 
11  
 
 
 
68 
 
8 
a- Two equivalents of 2-aminophenol were used 
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Table 3: Reaction of 2-aminophenols (1a-b) with benzaldehydes 2a–t (1:1 ratio) in acetate buffer (pH 
4.0) and acetonitrile under air at room temperature 
 
12  
 
 
 
56 
 
2 
 
13  
 
 
 
48 
 
2 
 
14  
 
 
 
93 
 
2 
 
15  
 
 
 
95 
 
2 
 
 
16 
 
 
 
 
 
72 
 
18 
 
17 
 
 
 
 
 
98a 
 
2 
a- Two equivalents of 2-aminophenol were used 
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Table 3: Reaction of 2-aminophenols (1a-b) with benzaldehydes 2a–t (1:1 ratio) in acetate buffer (pH 
4.0) and acetonitrile under air at room temperature 
 
18  
  
 
94 
 
1 
 
19  
  
 
94 
 
2 
 
Based on the data collected from all the experiments, it was clear that the cyclisation step from 7 to 8 
was not taking place. This could be due to a number of reasons; One, it was assumed that precipitation 
of compound 7 from the solution during reaction could interfere with the cyclisation process. In order 
to account for this a biphasic system was designed, where the enzyme was in the aqueous phase and 
substrate in the organic phase (Figure 14). Two, the redox potential of the enzyme; laccase origin 
could factor the oxidation potency of the enzyme; therefore reactions using different laccases were 
conducted. 
2.2.1. Biphasic Systems for laccase oxidation reaction 
 
Figure 14: Biphasic system for laccase oxidation reactions. 
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It was assumed that the cyclisation step from Schiff base 7 to intermediate 8 was not occurring 
because intermediate Schiff base 7 precipitates out of solution during the reaction process. This effect 
causes the entire reaction medium to solidify, thereby preventing the Schiff base from cyclising. 
Therefore the design of biphasic systems, where the substrate will be in the organic phase and enzyme 
will be in aqueous phase (buffer) was suggested as a way to resolve this problem. Schiff base 7 was 
dissolved in an organic solvent (upper layer) and the enzyme was in the Acetate buffer (pH 4.50) 
(lower layer) and the contents were stirred at a lower rate for 12-36 h (Scheme 18).   
 
             Scheme 18: Laccase-catalysed oxidation of intermediate 7 to benzoxazole derivative 
Organic solvents such as ethyl acetate, chloroform, and DCM were tested using two laccases 
(Suberase® and Novoprime base 268); however no activity was observed from all the substrates 
tested; only starting material was recovered. Cho et al. (2012) reported that the oxidative cyclisation 
from 7 to 8 is an equilibrium step and this step is the rate-determining step for the entire process. It 
was demonstrated that ortho-aminophenol is not sufficiently nucleophilic to facilitate cyclisation and it 
would require the use of an external nucleophile to facilitate ring closure [105]. 
Based on the assumption that there is equilibrium between Schiff base 7 and intermediate 8; the 
overall reaction rate for the production of benzoxazoles could be increased by making use of a strong 
oxidant.  Therefore our second approach was to test if the use of different enzymes would have any 
significant influence towards the formation of benzoxazoles based on their redox potential. The 
enzymes employed were Novozymes laccases (Suberase®, Denilite® II Base, and Novoprime Base 
268). Nevertheless, the oxidative cyclization reaction did not proceed; same results as before were 
obtained for all the tested enzymes as depicted in Table 3.  
As previously mentioned, when dealing with compounds possessing a higher redox potential than 
laccase, laccase-mediator systems can be used to overcome this obstacle and increase the oxidation 
aptitude of the enzyme [17].  Since we were unable to initiate the oxidative cyclisation of the substrates 
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to benzoxazole derivatives our next solution was to use a mediator (ABTS) to enhance the redox 
potential of the enzyme. Reactions of 2-aminophenols with benzaldehydes were conducted using the 
previously described general method together with ABTS as a mediator (Scheme 19). In these 
conditions dimerization of 2-aminophenol was observed and the products isolated were 2-amino-
phenoxazin-3-one (4a) (54%) (Scheme 16) along with Schiff base 7 and traces of starting material. No 
traces of benzoxazoles were observed in these conditions; this confirms that the cyclisation step is 
indeed the rate-determining step for the whole process as reported by Cho et al. (2012).  
2.2.2. Laccase-Mediator oxidation reactions 
 
                Scheme 19: Synthesis of benzoxazole derivatives catalysed by a laccase-mediator system 
In order to avoid oxidation and dimerization of 2-aminophenol to form 4a, reactions were conducted 
without the mediator to first generate compound 7 at room temperature. The products obtained were 
purified and then treated with laccase and ABTS (2.0 mL) at room temperature using different 
solvents and no activity was observed in all the substrates tested over a period of 72 h; only starting 
material was recovered (Scheme 20). It was determined that in the presence of a mediator the 
favourable reaction is the dimerization reaction of 2-aminophenol to 4a in good yield. In literature 
there are numerous reports on the laccase-mediated synthesis of phenoxazinone derivatives obtained 
from oxidative dimerization of various substituted 2-aminophenols [31, 106]. In this project, only one 
phenoxazinone product (2-amino-3H-phenoxazin-3-one (4a)) was synthesised in a reasonable yield of 
54 %. Even though synthesis of 2-aryl-benzoxazoles was not achieved, we successfully described an 
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easy and effective method for the synthesis of aminophenol derivatives which are important building 
blocks for benzoxazoles. With further optimization of the reaction conditions using laccases and also 
consideration of other oxidants, this method could be useful for effectively preparing benzoxazoles. 
2.2.3. Laccase Mediator Systems 
 
  Scheme 20: Oxidative cyclisation of Intermediate 7 catalysed by a laccase-mediator system 
As mentioned before, the Schiff base 7 products were characterized using 1H and 13C NMR, IR and 
high resolution mass spectrometry. Key signals (1H and 13C NMR) for selected compounds are 
summarised in Tables 4 and 5. 
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Table 4: Key signals in the 1H NMR spectra of amino phenols 
 
Compound Aromatic region 
(ppm) 
OH (ppm) Aliphatic region 
(ppm) 
7a 9.03 (1H, s, H7’); 8.09 
(1H, d, H3’); 7.12 (1H, 
t, H5); 6.80 (1H, t, H4) 
Not observed - 
7b 8.78 (1H, s, H7’); 8.74 
(1H, s, H2) 
7.15 (1H, s, OH), - 
7c 8.55 (1H, s, H7’); 7.14 
(2H, s, H6’, H2’); 7.07 
(1H, s, H3) 
Not observed 3.93 (9H, s, 3 x OMe); 
2.31 (3H, s, CH3) 
7o 8.77 (2H, d, H5’, H4’); 
8.69 (1H, s, H7’); 7.75 
(2H, d, H3’, H5’) 
7.25 (2H, m, H4, OH) - 
7p 8.55 (1H, s, H7’), 7.80 
(2H, d, H2’, H6’), 
7.24 (1H, s, OH) 3.07 (6H, s, 2 X CH3 ) 
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Table 5: Key signals in the 13C NMR spectra of amino phenols 
Compound Aromatic region (ppm) -OMe (ppm) -CH3 (ppm) 
7a 153.43 (C-7’), 152.55 (C-1), 136.21 (C-2), 
135.37 (C-2’), 132.89 (C-1’), 132.32 (C-4’) 
- - 
7b 153.90 (C-7’), 152.71 (C-1), 148.80 (C-3’), 
137.48 (C-2), 134.47 (C-1’), 133.96 (C-6’), 
130.13 (C-5’), 129.96 (C-5) 
- - 
7c 156.82 (C-7’), 153.55 (C-3’), 149.80 (C-
5’), 141.28 (C-1), 135.36 (C-4’), 131.37 
(C-2), 129.41 (C-1’), 119.71 (C-4) 
61.02 (OMe-12); 
56.25 (OMe-10) 
20.69 (CH3) 
7o 154.33 (C-7’), 152.87 (C-3’, C-5’), 150.69 
(C-1’), 142.40 (C-1), 134.43 (C-2), 130.41 
(C-6’, C-2’) 
- - 
7p 157.15 (C-7’), 152.70 (C-4’), 151.89 (C-1), 
136.65 (C-2), 130.55 (C-1’), 127.36 (C-2’, 
C-6’), 124.05 (C-5), 119.93 (C-4) 
- 40.14 (2 X CH3) 
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2.3. Synthesis of benzimidazole derivatives 
Laccase catalysed the synthesis of benzimidazole derivatives from reactions of aldehydes with 
derivatives of o-phenylenediamine using molecular oxygen as an oxidant. Leutbecher et al. (2011) 
discovered the laccase catalysed domino reaction between o-phenylenediamine with various aromatic 
aldehydes in aerobic conditions using a phosphate buffer and obtained 2-aryl-1H-benzimidazoles in 
good to excellent yields. It was discovered that when the reaction was carried out in the absence of 
laccase, otherwise under identical reaction conditions chemo-selectivity problems were encountered; 
where the reaction led to the formation of 2-substituted and 1,2-disubstituted benzimidazoles. 
However, in the presence of laccase chemo-selectivity was improved tremendously. Because most of 
the benzaldehyde substrates were not soluble in the buffer alone, methanol was used as a co-solvent to 
enhance the solubility of the substrates. However, it was under these reaction conditions where other 
reactions took place; reactions resulted in the formation of 2-substituted benzimidazole (11) and 1,2-
disubstituted benzimidazole (12) as a side product and sometimes the latter could be isolated as the 
only product (Scheme 21) [83]. Although this protocol has been proven effective, the main 
disadvantage of this method is chemo-selectivity. Therefore it is important to develop a new laccase-
catalysed synthetic methodology that is both effective and chemo-selective.  
 
Scheme 21: Laccase catalysed reaction of 1 and 2 in acetate buffer (pH 4.5) using various co-solvents. 
It has been shown that in the presence of an oxidizing agent the reaction favours the formation of 
product 11 over product 12 [92]. Following this, our aim was to first identify how and why the 1-
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benzylated side product was formed and if its formation could be controlled and possibly be 
eliminated. Our initial approach was to investigate the selectivity of these reactions by varying the types 
of buffers and co-solvents used in the synthesis of these compounds. The co-solvents used in this 
study were methanol, ethanol, DMF, and acetonitrile and the buffers were acetate and phosphate at 
different pH values. To explore the role of various solvents towards selectivity, we investigated the 
reaction between o-phenylenediamine (9a) with benzaldehydes 10a–d (Figure 15) (1:2 ratio) in acetate 
buffer (pH 4.5) using laccase Suberase® from Novozymes at room temperature (Scheme 21). The 
reaction times for these reactions varied from 2 to 24 h; it was observed that for the majority of the 
substrates, the mono-substituted product (11) forms first and then followed by the 1-benzylated 
product (12). Therefore 24 h of reaction time was selected for the model studies to further increase the 
yield of compound 12. Inferior results were obtained while using methanol and ethanol as co-solvents, 
as they both showed a great deal of competitive formation of products 11 and 12. Good chemo-
selectivity was observed with DMF and acetonitrile; with DMF we were able to minimize the 
formation of the 1-benzylated product, however some of the substrates resulted in the formation of 
side product 12 (Table 6). The results obtained compare to the ones reported in literature; using 
methanol as a co-solvent promoted the formation of product 12 and DMF promoted the formation of 
product 11 under the described reaction conditions [83, 88].   
 
Figure 15: O-phenylenediamine and aromatic aldehydes used in this study 
The relative ratios of products 11 and 12 obtained by laccase-catalysed oxidation were profoundly 
influenced by the type of organic solvent used. Similar results were obtained using a different laccase 
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(Denilite® II base from Novozymes) which indicates the significance of the nature of the organic 
solvent for the laccase oxidation of phenolic Schiff bases to form 2-benzimidazoles. 
Table 6: Reaction of o-phenylenediamine (9a) with benzaldehydes 10a–d (1:2 ratio) in acetate buffer 
(pH 4.5) and a co-solvent under air at r.t., 24 h to afford product 11 and/or 12 
Entry Aldehyde Co-solvent 11 yield (%) 12 yield (%) 
1 10a Methanol 59 20 
2 10a Ethanol - 13 
3 10a DMF 72 - 
4 10a Acetonitrile 62 - 
5 10b Methanol - - 
6 10b Ethanol - 97 
7 10b DMF - 98 
8 10b Acetonitrile - 82 
9 10c Methanol 10 90 
10 10c Ethanol 25 70 
11 10c DMF - 94 
12 10c Acetonitrile - 56 
13 10d Methanol 34 66 
14 10d Ethanol - - 
15 10d DMF 67 23 
16 10d Acetonitrile 59 36 
 
Our second approach was to explore the possible effect of the type of laccase used on selectivity of 
these reactions. When Fan et al. (2015) developed a highly chemo-selective method for either 2-
benzimidazoles or 1, 2-benzimidazoles; it was demonstrated that the presence of a strong oxidizing 
agent such as hydrogen peroxide influences the production of the 2-substituded benzimidazoles over 
the 1,2-disubstituted benzimidazoles [92]. This implies that the redox potential of the laccase used 
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strongly influences the chemo-selectivity of the reactions. Therefore, using laccases (Suberase®, 
Denilite® II Base, and Novoprime Base 268) from Novozymes, we investigated the role of enzyme 
type on these reactions. The reaction between o-phenylenediamine (9a) with benzaldehydes 10d was 
chosen as a model reaction and it was performed using an acetate buffer (pH 4.5) and acetonitrile at 
room temperature (Scheme 22), and the results are shown in Figure 16.   
 
Scheme 22: Laccase-catalysed reaction of 9a and 10d in acetate buffer (pH 4.5) using acetonitrile as a co-solvent. 
From the findings, it clearly indicates that the specific laccase influences the chemo-selectivity of 
benzimidazole derivatives to a great extent, based on the redox potential of each enzyme. Novoprime 
Base 268 (uncertain origin) presented the best oxidation results compared to the two laccases 
preparations from Myceliophthora thermophile (Suberase® and Denilite® II Base) for the formation of 2-
(3,4-dimethoxyphenyl)-1H-benzimidazole (11d). The reaction conducted using Suberase® as our 
laccase afforded a yield of 59% of the 2-substituted benzimidazole 11d and 36% was the 1,2-
disubstituted benzimidazole 12d. When using Denilite® II Base as our laccase, the ratio was 57% 
compound 11d and 30% compound 12d. And finally with Novoprime Base 268 we were able to 
produce 78% of compound 11d and compound 12d was not formed in these reaction conditions.  
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Figure 16: Suberase® and Denilite® are laccases from Myceliophthora thermophile. Novoprime – uncertain origin 
Finally, in order to identify the optimal conditions for these reactions we also considered the effects of 
using different buffers and pH towards the reaction selectivity. Leutbecher et al. (2011) investigated the 
effect of different buffers using acetate and phosphate buffers while varying buffer/co-solvent ratios. 
It was shown that the ratios of buffer/co-solvent affect chemo-selectivity and consequently the yield 
of the products formed [83]. In this study the buffer and pH studies were conducted using phosphate 
buffer (0.1 M, pH 6.0; 7.15; 7.5) and acetate buffer (0.1 M, pH 3.0; 4.0; 4.5; 5.0) systems using DMF 
and acetonitrile as co-solvents at room temperature. Reactions at lower pH values (3.0; 4.5; 5.0) 
occurred at faster rates than reactions carried out at higher pH values (7.15; 7.5).  
Using the discovered optimal conditions (General method), derivatives of o-phenylenediamine were 
treated with a series of aromatic aldehydes using commercial laccase, Novoprime Base 268, from 
Novozymes at room temperature and the obtained results are summarised in Table 7 below.  
General method used to synthesize 2-aryl-1H-benzimidazole derivatives 
A mixture of o-phenylenediamine (10.0 mmol, 1 equiv) and benzaldehyde derivative (10.0 mmol, 1 
equiv) in acetonitrile (10.0 mL) and acetate buffer (10.0 mL, pH 4.50) was stirred at room temperature 
for 5 minutes. Laccase (Novoprime Base 268 (0.105 g)) was added to the mixture and the contents 
0
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were stirred until reaction completes (monitored by TLC). The product precipitates from the solution 
as the reaction proceeds and after completion, the product was extracted with ethyl acetate (30.0 mL) 
and water (3 x 20.0 mL) and concentrated on a rotary evaporator. The product was washed several 
times with cold acetonitrile (3 x 20.0 mL) to remove any excess starting material.  
 
Scheme 23: Synthesis of 2-aryl-1H-benzimidazoles 
Table 7: Reaction of o-phenylenediamines (1 equiv) and benzaldehyde derivatives (1 equiv) in 
acetonitrile and acetate buffer (pH 4.0) at room temperature 
Entry Amine Benzaldehyde Product Yield 
(%)  
Time 
(h) 
 
1  
 
 
 
92 
 
2 
 
2  
  
 
94 
 
2 
 
3 
 
 
 
 
 
 
88 
 
4 
a- Two equivalents of o-phenylenediamines were used 
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Table 7: Reaction of o-phenylenediamines (1 equiv) and benzaldehyde derivatives (1 equiv) in 
acetonitrile and acetate buffer (pH 4.0) at room temperature 
 
4  
 
 
 
56 
 
8 
 
5  
 
 
 
79 
 
8 
 
6 
 
 
 
 
 
 
78 
 
8 
 
7 
 
 
 
 
 
 
 
60 
 
2 
 
8 
 
 
 
 
 
86 
 
4 
 
9 
 
 
 
 
 
 
64 
 
8 
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Table 7: Reaction of o-phenylenediamines (1 equiv) and benzaldehyde derivatives (1 equiv) in 
acetonitrile and acetate buffer (pH 4.0) at room temperature 
 
10 
 
 
 
 
 
 
98 
 
12 
 
11 
 
  
 
 
 
95 
 
2 
 
12 
 
 
 
 
 
89 
 
24 
 
13 
 
 
 
 
 
 
 
69 
 
24 
 
14  
  
 
93 
 
2 
 
15  
 
 
 
94 
 
4 
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Table 7: Reaction of o-phenylenediamines (1 equiv) and benzaldehyde derivatives (1 equiv) in 
acetonitrile and acetate buffer (pH 4.0) at room temperature 
 
16  
 
 
 
68 
 
24 
 
17 
 
 
 
 
 
 
98a 
 
12 
 
18 
 
  
 
 
 
76 
 
24 
 
19 
 
  
 
 
90 
 
3 
a- Two equivalents of o-phenylenediamines were used 
As shown in Table 7 above, 2-aryl-1H-benzimidazoles were obtained in good to excellent yields from 
different aromatic aldehydes. It is clear the method applies for a variety of aryl aldehydes containing 
both electron-donating and electron-withdrawing substituents around the ring. The structures of the 
obtained products were characterized using proton and carbon NMR and the keys signals for selected 
compounds are summarised in the Tables 8 and 9 bellow. Similar to benzoxazole derivatives, some of 
the substrates did not cyclise further to the final product (11 and/or 12) (Table 7, entry 10 and 17). 
The formation of the 1, 2-disubstituted benzimidazole product was anticipated in this case, taking into 
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account the fact that it does not require an external oxidant in order to form. As shown in Scheme 24 
below; after the condensation of the diamine and the aromatic aldehyde, the subsequent ‘intermediate’ 
benzimidazoline i may condense further with another molecule of benzaldehyde to afford another 
‘intermediate’ iminium ion ii. Successively, this intermediate may tautomerize to the most stable form 
iii and reshuffle to give out the resultant disubstituted benzimidazole product 12 [88]. 
 
Scheme 24: Synthesis of the 1, 2-disubstituted benzimidazole product 
In summary, our results correspond to literature reports; we have shown that the absence of an 
external oxidant and the use of organic solvents such as ethanol and methanol promotes the formation 
the 1,2-disubstituted product [83, 88]. We have demonstrated that using acetonitrile or DMF in the 
presence of a catalytic amount of laccase (Novoprime base 268) promotes the formation of the mono-
substituted benzimidazole. Our method is simple, selective and can afford 2-aryl-1H-benzimidazoles in 
good to excellent yields (Key signals of some of the products obtained are summarized in Tables 8 
and 9). 
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Table 8: Key signals in the 1H NMR spectra of 2-aryl-1H-benzimidazoles 
 
Compound Aromatic region (ppm) NH (ppm) Aliphatic region 
(ppm) 
11a 8.33 (1H, d, H6’), 7.63 (2H, dd, H5, 
H8), 7.48 (1H, t, H4’), 7.24 (1H, d, H7) 
12.11 (1H, s, NH) 4.03 (3H, s, 
OMe) 
11e 8.19 (2H, d, H2’, H6’), 7.68 (1H, d, H8), 
7.53 (4H, m, H5, H7, H3’, H5’) 
12.89 (s, 1H, NH) - 
11l 8.43 (1H, s, H7’), 7.78 (2H, d, , H2’, 
H6’), 6.95 (1H, d, H6), 6.85 (1H, s, H3) 
5.31 (2H, s, NH) 3.00 (6H, s, N-
CH3) 
12a 7.67 (1H, d, H6’), 7.52 (1H, t, H5’), 7.42 
(1H, d, H7’’), 7.36 (1H, d, H3’), 7.27 – 
7.12 (4H, m, H6, H7, H8, H4’), H4’’),  
- 5.21 (2H, s, H1’’) 
12b 9.77 (1H, d, H6’), 9.43 (1H, s, H2’), 7.73 
(1H, d, H8), 7.39 (1H, d, H5), 7.33 (1H, 
q, H5’), 7.23 (3H, td, H6, H7, H6’’), 
7.17 – 7.06 (2H, m, H1’’) 
- 5.49 (2H, s, H1’’) 
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Table 9: Key signals in the 13C NMR spectra of 2-aryl-1H-benzimidazoles 
Compound Aromatic region (ppm) -OMe (ppm) -CH2, -CH3 
(ppm) 
11a 157.25 (C-2), 149.43 (C-2’), 143.20 (C-9), 
135.19 (C-4), 131.70 (C-6’), 130.23 (C-4’), 
122.51 (C-5’), 121.96 (C-1’), 121.34 (C-3’) 
56.25 (OMe) - 
11e 151.69 (C-2), 144.29 (C-9, C-4), 135.47 (C-1’), 
130.65 (C-4’), 130.29 (C-3’, C-5’), 129.40 (C-
2’), 126.90 (C-6’) 
- - 
11l 157.60 (C-7’), 152.76 (C-4’), 145.55 (C-1, C-2), 
136.21 (C-1’), 130.76 (C-2’, C-6’), 124.66 (C-5), 
119.01 (C-6), 118.80 (C-3) 
- Not observeda 
12a 157.53 (C-3’’), 156.83 (C-2’), 152.31 (C-2), 
143.35 (C-4), 135.68 (C-9), 132.39 (C-6’), 
132.02 (C-4’), 129.17 (C-7’’), 127.94 (C-5’’), 
124.64 (C-2’’), 122.66 (C-7), 122.03 (C-6), 
120.98 (C-5’), 120.57 (C-6’’), 120.00 (C-1’) 
55.75 (OMe), 
55.73 (OMe) 
43.25 (C-1’’) 
12b 156.09 (C-3’), 155.91 (C-4’’), 151.69 (C-2), 
140.98 (C-4), 136.71 (C-9, C-2’’), 134.25 (C-1’), 
129.58 (C-5’), 128.19 (C-6’’), 120.96 (C-7), 
120.52 (C-6), 117.87 (C-6’) 
- 45.81 (C-1’’) 
a- For the exact structure, refer to compound 11l in Section 4.7.11 
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2.4. Synthesis of benzothiazole derivatives 
It has been mentioned that condensation–dehydration reaction of 2-aminothiophenol with aryl 
aldehydes under oxidative conditions is one of the traditional methods for preparing benzothiazoles. 
However, with an increasing demand for the development of green processes, the preparation of 2-
arylbenzothiazoles using environmentally friendly reagents such as biocatalysts is of great importance. 
Herein we report an effective method for the one-pot synthesis of 2-arylbenzothiazoles from 
condensation–dehydration reaction of 2-aminothiophenol with aryl-aldehydes in the presence of a 
catalytic amount of a commercially available laccase (Suberase® from Novozymes). To the best of our 
knowledge, a laccase-catalysed synthesis of 2-arylbenzothiazoles from condensation–dehydration 
reaction of 2-aminothiophenol with aryl-aldehydes has not been reported before.  The model reaction 
selected was the oxidative condensation between 2-aminothiophenol (13) and benzaldehyde (14a) 
under aerobic conditions at room temperature. The laccase-catalysed cross-coupling reaction between 
13 and 14a to afford 2-phenyl-benzothiazole (15a) (Figure 17) in 85% yield was performed in an 
acetate buffer (0.1 M, pH 4.0) using acetonitrile (50%) as a co-solvent (Scheme 24, Table 7, entry 4). 
 
Figure 17: Products 15a–h of the laccase-catalysed domino reaction between 13a and 14a–g. 
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The effect of organic solvents used when preparing benzothiazoles has been demonstrated in 
literature; solvents such as ethanol, acetonitrile, hexane, chloroform, DMSO and water have been 
investigated [106, 107]. Sayyahi et al. (2015) identified ethanol as the best solvent for preparing 2-
arylbenzothiazoles under reflux conditions [107]. Gao et al. (2014) described water as the optimal 
solvent using KI catalyst [108].   Therefore, in order to identify optimum reaction conditions we 
explored the effect of using various co-solvents. 2-Aminothiophenol (13) and benzaldehyde (14a) were 
reacted in the presence of a laccase (Suberase®, from Novozymes) in acetate buffer (pH 4.0) using 
various solvents at room temperature (Table 10).  
 
Scheme 25: Laccase-catalysed synthesis of 2-phenyl-benzothiazole 
Table 10: Laccase-catalysed synthesis of 2-phenyl-benzothiazole (15a) by reaction of 2-
aminothiophenol (13) and benzaldehydes 14a in acetate buffer (0.1 M, pH 4.0) using various co-
solvents 
Entry Aldehyde Co-solvent Time (h) Product Yield (%) 
1 14a Methanol 24h 15a 58 
2 14a Ethanol 24h 15a 55 
3 14a DMF 24h 15a 78 
4 14a Acetonitrile 2h 15a 85 
5 14a DCM 24h 15a 65 
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Acetonitrile gave the best yield under the described reaction conditions. When the reaction completes 
the product precipitates out of solution and any remaining starting material can be washed with cold 
acetonitrile to yield pure product. While using methanol and ethanol as co-solvents, the reaction did 
not go to completion after 24 h of reaction and the product (15a) (yellow oil) was difficult to isolate 
from the starting material (2-aminothiophenol (13)) as they both have almost indistinguishable Rf 
values (40% EtOAc/hexane). Sayyahi et al. (2015) obtained excellent yields using ethanol and the 
reaction did not go to completion while using acetonitrile, when using the ionic liquid [bmim][FeCl4] as 
a catalyst [107]. However, we obtained inferior results while using laccase as an oxidising agent in 
ethanol, while conversely acetonitrile gave an excellent yield. In order to purify compound 15a from 
the starting material, the product was dried overnight under high-vacuum to completely dry-out the 
oily product to almost solid form, and cold acetonitrile was added to propel precipitation of the 
product. As mentioned before, another amount of cold acetonitrile (3 x 20.0 mL) was used to wash the 
starting material off the product.  
In order to elucidate the role of the enzyme as a catalyst, control reactions were conducted using 
benzaldehydes 14a–h under air in acetate buffer (0.1 M, pH 4.0)/acetonitrile (50:50) in the absence of 
laccase (Scheme 26). However only two substrates resulted in the formation of a fused product in 
very low yield (<10%) and no activity was observed for the remaining substrates (Table 11). 
Conversely, quantitative yields of the same substrates were obtained in the presence of an enzyme. 
 
Scheme 26: Laccase-free synthesis of benzothiazoles 
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Table 11: Reaction of 1 equiv of 2-aminothiophenol (13) with 1 equiv of benzaldehydes 14a–h in 
acetate buffer (0.1 M, pH 4.0)/acetonitrile (50:50), for 24 h in the absence of laccase 
Entry Aldehyde Product Yield (%) 
1 14a 15a - 
2 14b 15b 8 
3 14c 15c - 
4 14d 15d - 
5 14e 15e 7 
6 14f 15f - 
7 14g 15g c 
8 14h 15h - 
                       c - Two equiv of 2-aminothiophenol (13) were used and no product was obtained 
At this point, the most efficient method presenting the highest catalytic activity for preparing 2-
arylbenzothiazoles was using acetonitrile and acetate buffer (pH 4.0), similar to the method described 
for 2-aryl-benzimidazole. Therefore to study the range and limitations of the optimised procedure 2-
aminothiophenol was treated with a series of aryl-aldehydes in the presence of a catalytic amount of 
laccase to yield 2-arylbenzothiazole derivatives in good to excellent yield at room temperature (General 
method) and the results obtained are summarized in Table 12.  Similar reactivity was observed for 
benzaldehydes with a variety of substituent groups; both electron-withdrawing and electron-donating 
at various positions showed comparable yields and reaction rates. 
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General method used to synthesize 2-aryl-benzothiazole derivatives 
A mixture of 2-aminothiophenol (1.63 g, 15.0 mmol) and benzaldehyde derivative (1.06 g, 10.0 mmol) 
in acetonitrile (10.0 mL) and acetate buffer (10.0 mL, pH 4.0) was stirred at room for 5 minutes. 
Suberase® (2.00 mL) was then added into the mixture and the contents were stirred for 1 h. When the 
reaction completes, the product precipitates from the solution and was extracted with ethyl acetate 
(30.0 mL) and water (3 x 20.0 mL) and concentrated on a rotary evaporator. The product was washed 
several times with cold acetonitrile (3 x 20.0 mL) to remove any excess starting material.  
Table 12: Reaction of 2-aminothiophenol (1.5 equiv) and benzaldehyde derivatives (1 equiv) in 
acetonitrile and acetate buffer (pH 4.00) at room temperature 
Entry Amine Benzaldehyde Product Yield 
(%)  
Time 
(h) 
1 
 
 
 
 
85 
 
24 
2 
 
 
 
 
 
56 
 
24 
3 
 
 
 
 
 
68 
 
24 
4 
 
  
 
73 
 
24 
5 
 
  
 
65 
 
24 
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Table 12: Reaction of 2-aminothiophenol (1.5 equiv) and benzaldehyde derivatives (1 equiv) in 
acetonitrile and acetate buffer (pH 4.00) at room temperature 
6 
 
 
 
 
56 
 
 
24 
7 
 
  
 
88 
 
24 
8 
 
  
 
87a 
 
24 
9 
 
  
 
76 
 
24 
10 
 
  
 
48 
 
24 
11 
 
  
 
74 
 
24 
12 
 
  
 
84 
 
24 
a- Two equivalents of 2-aminothiophenol were used 
We have successfully developed a simple and efficient method for the synthesis of 2-arylbenzothiazole 
derivatives using laccase as a catalyst at room temperature. The structures proposed are consistent with 
analytical data from the literature. Key signals for selected 1H and 13C NMR spectra are shown in 
Tables 13 and 14. 
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Table 13: Key signals in the 1H NMR spectra of 2-aryl-benzothiazoles 
 
Compound Aromatic region (ppm) Aliphatic region (ppm) 
15a 8.15 – 8.04 (3H, m, H8, H2’, H6’), 7.91 (1H, 
d, H5), 7.50 (4H, m, H6, H7, H3’, H5’) 
- 
15b 8.03 – 7.91 (2H, m, H2’, H6’), 7.84 (1H, d, 
H5), 7.44 (1H, t, H6), 7.30 (1H, t, H7) 
3.01 (6H, d, N-CH3) 
15c 8.04 (3H, d, H5, H2’, H6’), 7.88 (1H, d, H8), 
7.47 (1H, t, H6), 7.35 (1H, t, H7) 
3.88 (3H, s, OMe) 
15g 8.78 (2H, d, H3’, H5’), 8.13 (1H, d, H5), 7.99 
– 7.87 (3H, m, H8, H2’, H6’) 
- 
15i 8.68 (1H, d, H5), 8.10 (1H, d, H8), 7.93 (1H 
d, H3’), 7.57 – 7.46 (2H, m, H6, H6’) 
4.04 (3H, s, OMe) 
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Table 14: Key signals in the 13C NMR spectra of 2-aryl-benzothiazoles 
Compound Aromatic region (ppm) -OMe (ppm) -CH3 (ppm) 
15a 154.17 (C-2), 135.08 (C-4), 133.65 (C-1’), 
130.97 (C-9), 129.03 (C-2’, C-6’), 127.57 (C-
5’), 126.32 (C-3’), 125.19 (C-4’) 
- - 
15b 168.79 (C-2), 154.43 (C-4’), 152.20 (C-4), 
134.56 (C-9), 128.87 (C-6’), 127.71 (C-2’), 
125.97 (C-6), 125.29 (C-7), 124.18 (C-1’) 
- 40.48 (N-CH3) 
40.18 (N-CH3) 
15c 167.85 (C-2), 161.94 (C-4’), 154.24 (C-4), 
134.87 (C-1’), 129.12 (C-9), 126.47 (C-6’), 
126.19 (C-2’), 124.79 (C-6), 122.83 (C-7) 
55.46 (OMe) - 
15g 165.10 (C-4), 153.99 (C-2), 150.77 (C-3’, C-
5’), 140.49 (C-1’), 135.23 (C-9), 126.82 (C-6), 
126.20 (C-7), 123.94 (C-8) 
- - 
15i 161.43 (C-2), 156.22 (C-5’), 152.00 (C-4), 
136.20 (C-1’), 134.12 (C-9), 131.88 (C-3’), 
126.11 (C-6), 124.93 (C-7), 124.05 (C-8) 
56.03 (OMe) 
 
- 
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2.5. Synthesis of aminobenzoquinones 
There are a limited number of reports on the synthesis of aminobenzoquinones derived from 
amination of hydrobenzoquinones by aliphatic and aromatic amine using chemical oxidants. This is 
because there are a number of problems encountered when using chemical oxidants, these includes 
issues such as susceptibility of amino groups to oxidation and hydrolysis [2]. Other problems 
encountered using chemical oxidants include the issue of selectivity between the formation of 
monoaminated and diaminated products [109]. Chemical oxidants that have been successfully used to 
achieve amination of p-hydroquinones include sodium iodate, cupric acetate and silver (I) oxide [2, 
110]. It has been demonstrated in literature that laccases from different origins have a great influence 
on reactions [46, 48]. In this section we investigated how different laccases can be used to develop 
ideal conditions for the production and improvement of yields of the monoaminated and diaminated 
products for the synthesis of aminobenzoquinones. The laccase catalysed nuclear amination of 
aromatic hydrobenzoquinones with aliphatic and aromatic amine molecules was investigated at mild 
reaction conditions using commercial  laccases from Novozymes (Suberase®, Denilite® II Base, and 
Novoprime Base 268). Other factors that impact on reaction yield were explored; these include 
conducting reactions under dilute conditions, sequential addition of enzyme and substrate over time, 
and also the effect of buffer and co-solvents.    
 
Figure 18: Examples of p-hydrobenzoquinones and primary amines used in this study 
  67 
Wellington et al. (2010) demonstrated a laccase-catalysed synthesis of diaminobenzoquinones using the 
commercial laccase, Denilite® II Base (on an inert support) from Novozymes. The report describes an 
efficient protocol for preparing diaminobenzoquinones derived from p-dihydroxylated benzoic acid 
derivatives and aryl and alkyl primary amines [55]. A drawback of this method was that the yields of 
the products produced were exceedingly low. It was suggested that factors such as the number of 
equivalents of primary amines, effect of co-solvent and solubility of substrates and also laccase activity 
affected the formation of products. Following from this, our first approach to solve this problem was 
to investigate the effect of different co-solvents on the solubility of the substrate and how they impact 
the yields. Since it has been shown in a number of reports that nuclear amination reactions of p-
hydroquinones by primary amines favour the formation of diaminated products over monoaminated 
products; reactions were conducted using two equivalents of the primary amine [2, 55]. Following 
from Wellington et al. (2010) similar substrates were chosen (Figure 18), and we focused on the ones 
which resulted in lower yields and developed methods to make improvements. 
For the investigation of solvent effects on reaction yields, the laccase-catalysed reaction of 2,5-
dihydroxyacetophenone (10.0 mmol, 1.52 g) and 4-isopropylaniline (20.0 mmol, 2.70 g) in acetate 
buffer (20.0 mL, 0.1 M, pH 4.00) was chosen as the model reaction (Scheme 27). The reaction was 
carried out in the presence of various co-solvents such as methanol, DMF, and acetonitrile at room 
temperature and the results obtained are summarized in Table 15. Different reactivity and yields were 
observed while using different solvent systems, as reported by Wellington et al. (2010) [2]. 
 
 
Scheme 27: Laccase-catalysed reaction between 2,5-dihydroxyacetophenone and 4-isopropylaniline   
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Table 15: Reactions between 2,5 dihydroxyacetophenone and 4-isopropylaniline were catalysed by 
Denilite® II base in different co-solvent systems 
Entry Buffer/co-solvent (mL) Co-solvent Reaction time Product (22) 
yield 
1 9:1 Methanol 72 h 12% 
2 10:10 Acetonitrile 72 h 17% 
3 10:10 DMF 72 h 25% 
 
The reactions between 2,5-dihydroxyacetophenone and 4-isopropylaniline were catalysed by Denilite® 
II base from Novozymes in various solvent systems. The main obstacle in these reactions was the 
solubility of the substrate in the reaction vessel, as mentioned, the various co-solvents deployed helped 
to enhance the solubility of the substrates. For the tested solvents, methanol and acetonitrile showed 
poor results; the hydroquinone substrate tends to precipitate out of solution during the course of the 
reaction which then prevents the reaction from moving forward. DMF showed some promising 
results, however to an extent; the reaction moves forward for the first 6 hours before the substrate 
precipitates out. Because of this factor, the reactions were diluted to lower concentrations to reduce 
the effect of the substrate precipitating out of solution during the reaction. The 2,5-
dihydroxyacetophenone substrate was dissolved in DMF and was added dropwise to the mixture over 
time and this improved the yield significantly (Table 16). Since it is understood from literature that the 
role of laccase in the reaction is to oxidise the hydroquinone to a quinone [2]; the addition of the 
hydroquinone at a slower rate would ensure enough and fresh enzyme to oxidise the substrate. 
Wellington et al. (2010) reported that the reactions did not go to completion because the hydroquinone 
was not being completely converted to the quinone, therefore slow addition of hydroquinone with an 
increase of enzyme quantity would ensure complete conversion to quinone. 
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Table 16: Reactions between 2,5-dihydroxyacetophenone and 4-isopropylaniline were catalysed by 
Denilite® II base in different co-solvent systems under dilute conditions 
Entry Buffer/co-solvent (mL) Co-solvent Reaction time Product (22) 
yield 
1 36:4 Methanol 72 h 21% 
2 20:20 Acetonitrile 72 h 28% 
3 20:20 DMF 72 h 42% 
 
Our second approach was to investigate the effect of using different types of laccases for the oxidation 
of the hydroquinone substrates. Using DMF as the optimal co-solvent, various commercial laccases 
from Novozymes (Suberase®, Denilite® II Base, and Novoprime Base 268) were tested for the model 
reaction (Table 17). Novoprime Base 268 gave the best yield for these transformations using acetate 
buffer at room temperature. As discussed by Wellington et al. (2010), the enzymes becomes denatured 
over time during reaction; as a consequence it was decided to increase the amount of enzymes at 
different time intervals to reducing the possibility of the enzyme denaturing all at once. This effect 
improved the yields of some the products [2]. 
Table 17: Reactions between 2,5-dihydroxyacetophenone and 4-isopropylaniline catalysed by various 
laccases under dilute conditions 
Entry Buffer/DMF (mL) Laccase Reaction time 
(h) 
Product yield 
(%) 
1 20:20 Suberase® 72  19 
2 20:20 Denilite® II Base 72  42 
3 20:20 Novoprime Base 268 72  45 
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To account for solubility issues due to precipitation of substrate and the effect of enzyme denaturing 
during reaction, we decided to sequentially add both enzyme and substrate slowly over time to 
increase the reaction yield. This method proved to be very effective and was applied to various 
substrates and excellent yields were obtained (Table 18). 
Table 18: Reactions between 2,5-dihydroxyacetophenone (1 equiv) and primary amine (2 equiv) 
catalysed by Novoprime Base 268 under dilute conditions (using Method Z) 
Entry Hydroquinone Primary 
amine 
Product Reaction 
time (h) 
Yield (%) Yield (%) 
by 
Wellington 
et al. 
(2010) 
1 16a 17b 18 24 72 52 
2 16b 17a 19 72  100a - 
3 16b 17b 20 72  56 32 
4 16b 17c - 72  **b - 
5 16a 17a - 18 72c 32 
6 16c 17b 21 12 28d 20 
7 16d 17a 22 4 100 25 
a- The product obtained was the mono-aminate product not diaminated 
b- The actual yields were not obtained due to quinone decomposition during purification by column chromatography  
c- The yield obtained was lower compared to the conversion ( TLC) which was high, product decomposed during separation 
d- Product was not characterised due to decomposition during purification, yield based on previous experimental data.  
 
In summary, the combination of methods such as reactions under dilute conditions, sequential 
addition of enzyme and substrate over time, and using Novoprime Base 268 laccase; afforded five 
diaminobenzoquinones and one monoaminobenzoquinone (Table 18, entry 2) from the p-
hydrobenzoquinones in excellent yields (Figure 19). From the data in Table 18 it can be observed that 
the yields range from moderate (entry 6) to excellent (entries 1, 2 and 7) when the reactions were 
conducted using a combination of the described methods (Method Z). One monoaminated product 2-
(phenylamino)cyclohexa-2,5-diene-1,4-dione (entry 2) was obtained using one equivalent of p-
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hydrobenzoquinone and primary amine; from TLC results all the starting material was depleted after 
72 h of reaction and only a single product  was obtained. Some of the substrates were not fully 
characterised (entries 4 and 5) due to the effect of quinone decomposition on silica during purification 
by column chromatography, as detected by TLC. For product 21, the yield obtained was 28%, but 
better conversion was estimated from TLC during reaction; this implies that product could have been 
lost during purification. Nonetheless, the yield is an improvement on Wellington et al. (2010) (20%). A 
100% yield was obtained for the diaminated product 22 of which the highest obtained by Wellington et 
al. (2010) was 25%. Overall this method has proven to be successful for preparing both mono and 
diaminatedbenzoquinones at room temperature and could be applied to a much broader range of 
substrates.  
  
Figure 19: Structures of nuclear amination products 
. 
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C h a p t e r  3  
CONCLUSIONS AND FUTURE WORK 
The overall aim of the project was to investigate the range and limitations of applications of laccase 
enzymes in organic synthesis. We were able to study the catalysis of bond formation of reactions such 
as oxidation, amination, and dimerization precisely on cross-coupling reactions of Carbon, Nitrogen, 
Oxygen, and Sulphur based aromatic compounds using laccase as a catalyst. In total we produced 56 
compounds from four different classes.  
We investigated the potential use of laccases to synthesise biaryl bonds from substituted phenol 
substrates, but this synthesis was not accomplished. Instances of polymerisation were encountered a 
few times, however due to solubility problems the products were not characterised. Based on the 
literature, it could be argued that the laccases used in this study did not possess enough oxidative 
potency to initiate phenoxy radicals to generate biaryl bonds for most of the substrates.  
We investigated the synthesis of benzoxazoles; our main interest was to develop optimal conditions 
for the synthesis of benzoxazoles through a method that is selective and suitable for large scale 
preparations. We investigated the one-pot synthesis benzoxazoles from a condensation reaction 
between 2-aminophenol and aromatic aldehydes using laccase as an oxidizing catalyst. As the 
cyclisation of Schiff base 7 step did not take place, direct benzoxazole synthesis was not achieved.  
However we achieved the synthesis of the intermediate aminophenol derivatives, which are important 
building blocks for benzoxazoles, in good to excellent yields. Including ABTS as a reaction mediator 
under the same conditions resulted in the conversion of 2-aminophenol to 2-amino-3H-phenoxazin-3-
one (4) at a reasonable yield. With further optimization of the reaction conditions using laccases and 
possibly inclusion of other oxidants, this method may yet be useful for effectively preparing 
benzoxazoles. 
We investigated the selectivity factor for the production of 2-aryl-1H-benzimidazoles from the 
condensation reaction between o-phenylenediamine and benzaldehyde derivatives in the presence of a 
laccase. Laccase successfully catalysed the synthesis 2-aryl-1H-benzimindazole derivatives at room 
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temperature with high chemo-selectivity. The optimal conditions for conducting these reactions 
appear to be using Novoprime Base 268 in acetate buffer (0.1 M, pH 4.5) and acetonitrile as a co-
solvent, compared to phosphate buffer systems. Good results were also obtained using DMF and 
acetate buffer (0.1 M, pH 4.5), however the reactions were less selective in these conditions; some 
substrates led to formation of the disubstituted side product. Overall we have shown that the absence 
of a chemical oxidant, types of organic solvents used, and the oxidative potency of laccases 
significantly affect the chemo-selectivity of these reactions.  
We have also demonstrated that conducting reactions under dilute conditions, with gradual addition of 
enzyme and substrate over time, greatly improved the previously achieved reaction yields of 
aminobenzoquinones.  
Future work  
Develop optimal conditions for obtaining biaryl compounds by exploring different mediators and 
laccase enzymes. Further develop methods that promote ring closer such as the use of an external 
nucleophile and consideration of other laccase sources and mediators for the preparation of 2-aryl-
benzoxazoles.  
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C h a p t e r  4  
EXPERIMENTAL SECTION 
4.1. General 
All chemicals were reagent grade materials obtained from Sigma-Aldrich (South Africa).  
4.2. Materials 
The solvents used for reactions were methanol, ethanol, DCM, DMF, ethyl acetate and acetonitrile 
and were purchased from Sigma-Aldrich (South Africa) or Merck KGaA (South Africa). Purification 
of some of the compounds was done using Macherey-Nagel silica gel 60 (particle size 0.063 mm to 
0.20 mm) and the solvents used (ethyl acetate and hexane) were distilled before use to remove any 
impurities. Reactions were monitored by TLC carried out on Merck Aluminium foil backed plates 
coated with silica gel (60 F254) and visualization was done under UV light. 
4.3. Substrates 
All the substrates used were purchased from Sigma-Aldrich (South Africa) and were used as received 
without any further purification.  
4.4. Enzymes 
 Myceliophthora thermophilia laccases (Suberase® and Denilite® II Base) and Novoprime Base 268 
(uncertain origin) were obtained from Novozymes. 
4.5. Instrumentation 
All the melting point recordings of the compounds were performed on a Stuart SMP10 instrument. 
Bruker 300 and 500 MHz spectrometers were used to record both the 1H and 13C Nuclear Magnetic 
Resonance data using a suitable solvent at room temperature. Data processing of the spectra was done 
using MestreNova Software under license from Mestrelab Research, CA, USA. Bruker Tensor-27 
Fourier Transform spectrometer was used to perform infrared spectroscopy. 
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4.6. Synthesis of benzoxazole derivatives 
The following methods were used for the synthesis of benzoxazoles 
Method A 
A mixture of a 2-aminophenol derivative (10.0 mmol, 1 equiv) and benzaldehyde derivative (10.0 
mmol, 1 equiv) in acetonitrile (8.0 mL) and acetate buffer (0.1 M, 12.0 mL, pH 4.0) was stirred at room 
temperature for 5 minutes. Suberase® (2.0 mL) was then added into the mixture and the contents 
were stirred until the reaction completes (monitored by TLC). When the reaction completes, the 
product precipitates from the solution and was extracted with ethyl acetate (30.0 mL) and water (3 x 
20.0 mL). After extraction, the solvent was removed on a rotary evaporator to afford a solid product. 
The solid product was washed several times with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material.   
Method B 
The same as Method A, except that methanol (2.0 mL) was used instead of acetonitrile.  
Method C 
The same as Method A, except that ethanol (4.0 mL) was used instead of acetonitrile.  
Method D 
The same as Method A, except that dichloromethane (8.0 mL) was used instead of acetonitrile.  
Method E 
The same as Method A, except that DMF (8.0 mL) was used instead of acetonitrile.  
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Method F 
Intermediate 8 (3.0 mmol) was dissolved in ethyl acetate (4.0 mL) and was added to a mixture 
containing Suberase® (2.0 mL) and acetate buffer (0.10 M, 6.0 mL, pH 4.0). The reaction mixture was 
stirred overnight at room temperature and was monitored by TLC. 
Method G 
The same as Method F, except that chloroform (4.0 mL) was used instead of ethyl acetate. 
Method H 
The same as Method F, except that dichloromethane (4.0 mL) was used instead of ethyl acetate. 
Method I 
A repetition of method F-H using Novoprime Base 268 (0.105 g) instead of Suberase®. 
Method J 
A repetition of Method A using Denilite® II Base (0.085 g) and Novoprime Base 268 (0.105 g) 
laccases instead of Suberase® (2.0 mL). 
Method K 
A repetition of Method A using ABTS (2.0 mL) and Novoprime Base 268 (0.105 g) as laccase. 
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4.6.1.  Synthesis of (E)-2-((2-chlorobenzylidene)amino)phenol (8a) 
 
4.6.1.1.  METHOD A 
Stirring time = 30 min. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any 
excess starting material (confirmed by TLC) to afford a bright yellow solid (1.66g, 72%). Rf (40% 
EtOAc/hexane) 0.58. MP = 96 – 100 °C. 1H NMR (500 MHz, Chloroform-d): δ 9.03 (1H, s, H7’), 
8.09 (1H, d, J = 7.5 Hz, H6’), 7.35 – 7.17 (4H, m, H3’, H4’, H5’, H3), 7.12 (1H, t, J = 7.7 Hz, H5), 6.91 
(1H, d, J = 8.1 Hz, H6), 6.80 (1H, t, J = 7.6 Hz, H4). 13C NMR (126 MHz, Chloroform-d): δ 153.43 
(C-7’), 152.55 (C-1), 136.21 (C-2), 135.37 (C-2’), 132.89 (C-1’), 132.32 (C-4’), 130.13 (C-3’), 129.49 (C-
5), 128.32 (C-6’), 127.12 (C-5’), 120.19 (C-4), 116.19 (C-6), 115.18 (C-3). HRMS m/z: calculated for 
C13H10ClNO: 231.68, found: [M+H]: 232.05. IR (vmax/cm
-1): 3069 (ArC-H); 1582, 1561 (ArC=C); 
1122 (C-O); 710 (C-Cl). 
4.6.1.2.  METHOD B 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a yellow solid (1.66 g, 67%). Rf (40% EtOAc/hexane) 
0.58. 
4.6.1.3.  METHOD C 
Stirring time = 12 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a yellow solid (1.66 g, 70%). Rf (40% EtOAc/hexane) 
0.58. 
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4.6.1.4.  METHOD D 
Stirring time = 6 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a yellow solid (1.66 g, 70%). Rf (40% EtOAc/hexane) 
0.58. 
4.6.1.5.  METHOD E 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a yellow solid (1.66 g, 71%). Rf (40% EtOAc/hexane) 
0.58. 
 
4.6.2.  Synthesis of (E)-2-((3-nitrobenzylidene)amino)phenol (8b) 
 
4.6.2.1.  METHOD A 
Stirring time = 8 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a green-yellow solid (2.098 g, 87%). Rf (40% 
EtOAc/hexane) 0.78. MP = 136 – 142 °C. 1H NMR (500 MHz, Chloroform-d) δ 8.78 (1H, s, H7’), 
8.74 (1H, s, H2’), 8.34 (1H, d, J = 8.2 Hz, H6’), 8.25 (1H, d, J = 7.7 Hz, H4’), 7.68 (1H, t, J = 7.9 Hz, 
H5’), 7.34 (1H, d, J = 8.0 Hz, H3), 7.30 – 7.20 (1H, m, H5), 7.15 (1H, s, OH), 7.05 (1H, d, J = 8.1 Hz, 
H6), 6.94 (1H, t, J = 7.7 Hz, H4). 13C NMR (126 MHz, Chloroform-d) δ 153.90 (C-7’), 152.71 (C-1), 
148.80 (C-3’), 137.48 (C-2), 134.47 (C-1’), 133.96 (C-6’), 130.13 (C-5’), 129.96 (C-5), 125.77 (C-4’), 
123.31 (C-2’), 120.31 (C-4), 115.91 (C-6), 115.58 (C-3). HRMS m/z: calculated for C13H10N2O3: 
242.23, found: [M+H]: 243.08. IR (vmax/cm
-1): 3076 (ArC-H); 1582, 1510, (ArC=C); 1475&1375(N-
O); 1077 (C-O).  
  79 
4.6.3. Synthesis of (E)-4-methyl-2-((3,4,5-trimethoxybenzylidene)amino)phenol (8c) 
 
4.6.3.1.  METHOD A 
Stirring time = 3 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a dark green solid (2.098 g, 72%). Rf (40% 
EtOAc/hexane) 0.44. MP = 114 – 123 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.55 (1H, s, H7’), 
7.14 (2H, s, H2’, H6’), 7.07 (1H, s, H3), 7.00 (1H, d, J = 8.2 Hz, H5), 6.91 (1H, d, J = 8.2 Hz, H6), 3.93 
(9H, s, OMe), 2.31 (3H, s, CH3). 
13C NMR (126 MHz, Chloroform-d): δ 156.82 (C-7’), 153.55 (C-3’), 
149.80 (C-5’), 141.28 (C-1), 135.36 (C-4’), 131.37 (C-2), 129.41 (C-1’), 119.71 (C-4), 117.68 (C-5), 
116.58 (C-3), 115.15 (C-6), 105.83 (C-2’, C-6’), 61.02 (2 x OMe), 56.25 (OMe), 20.69 (CH3). HRMS 
m/z: calculated for C17H19NO4: 301.34, found: [M+H]: 302.13. IR (vmax/cm
-1): 3008 (ArC-H); 1573, 
1503, 1417 (ArC=C); 1371 (CH3); 118 (C-O).   
4.6.4.  Synthesis of (E)-4-methyl-2-((3-nitrobenzylidene)amino)phenol (8d) 
 
4.6.4.1.  METHOD A 
Stirring time = 1 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a dark green solid (2.459 g, 96%). Rf (40% 
EtOAc/hexane) 0.72. MP = 168 – 176 °C.  1H NMR (500 MHz, Chloroform-d): δ 8.75 (1H, s, H7’), 
8.72 (1H, s, H2’), 8.32 (1H, d, J = 8.7 Hz, H6’), 8.24 (1H, d, J = 7.7 Hz, H4’), 7.67 (1H, t, J = 7.9 Hz, 
H5’), 7.15 (1H, s, OH), 7.06 (1H, d, J = 8.2 Hz, H5), 7.01 – 6.88 (2H, m, H3, H6), 2.33 (3H, s, CH3). 
13C NMR (126 MHz, Chloroform-d): δ 153.50 (C-7), 150.51 (C-3’), 148.79 (C-1), 137.59 (C-2), 
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134.06 (C-1’), 133.88 (C-6’), 130.77 (C-4), 129.92 (C-5’), 129.60 (C-5), 125.65 (C-4’), 123.27 (C-2’), 
116.29 (C-3), 115.25 (C-6), 20.77 (CH3). HRMS m/z: calculated for C14H12N2O3: 256.26, found: 
[M+H]: 257.09. IR (vmax/cm
-1): 3069 (ArC-H); 1588, 1575 (ArC=C); 1516 &1344(N-O); 1371 (CH3); 
1075 (C-O). 
4.6.5.  Synthesis of (E)-2-((4-(dimethylamino)benzylidene)amino)-4-methylphenol (8e) 
 
4.6.5.1.  METHOD A 
Stirring time = 1 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a dark brown solid (2.359 g, 93%). Rf (40% 
EtOAc/hexane) 0.59. MP = 162 – 170 °C.  1H NMR (500 MHz, Chloroform-d): δ 8.54 (1H, s, H7’), 
7.79 (2H, d, J = 8.7 Hz, H2’, H6’), 7.07 (1H, s, H3), 6.93 (1H, d, J = 8.2 Hz, H5), 6.87 (1H, d, J = 8.1 
Hz, H6), 6.74 (2H, d, J = 8.7 Hz, H3’, H5’), 3.07 (6H, s, 2 x N-CH3), 2.31 (3H, s, CH3). 
13C NMR (126 
MHz, Chloroform-d): δ 156.83 (C-7’), 152.65 (C-4’), 149.64 (C-1), 136.24 (C-2), 130.49 (C-4), 127.87 
(C-5), 124.18 (C-2’, C-6’), 116.13 (C-1’), 115.12 (C-3), 114.04 (C-6), 111.59 (C-3’, C-5’), 40.17(2 x N-
CH3), 20.86 (CH3). HRMS m/z: calculated for C16H18N2O: 254.33, found: [M+H]: 255.15. IR 
(vmax/cm
-1): 3017 (ArC-H); 1586, 1547 (ArC=C); 1499 (CH3); 1364 (C-N); 1065 (C-O). 
4.6.6. Synthesis of 2,2'-((1E,1'E)-(1,4-
phenylenebis(methanylylidene))bis(azanylylidene))bis(4-methylphenol) (8f) 
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4.6.6.1.  METHOD A 
2-aminophenol (2 equiv), Stirring time = 1 h. Purification by washing with cold acetonitrile (3 x 20.0 
mL) to remove any excess starting material (confirmed by TLC) to afford a yellow solid (3.33 g, 97%). 
Rf (40% EtOAc/hexane) 0.78. MP = 226 – 231 °C.  
1H NMR (500 MHz, Chloroform-d): δ 8.73 
(2H, s, H7’, H7’’), 8.02 (4H, s, H2’, H3’, H5’, H6’), 7.16 (2H, s, OH), 7.09 (2H, s, H3’, H3’’), 7.04 (2H, 
d, J = 8.2 Hz, H5’, H5’’), 6.93 (2H, d, J = 8.2 Hz, H6’, H6’’), 2.33 (6H, s, 2 x CH3). 
13C NMR (126 
MHz, Chloroform-d): δ 155.37 (C-7’, C-7’’), 150.42 (C-1, C-1’’), 138.50 (C-1’, C-4’), 134.78 (C-4, C-
4’’), 130.13 (C-2, C-2’’), 129.45 (C-2’, C-3’, C-5’, C-6’), 129.08 (C-5, C-5’’), 116.22 (C-3, C-3’’), 114.91 
(C-6, C-6’’), 20.81 (2 x CH3).  HRMS m/z: calculated for C22H20N2O2: 344.41, found: [M+H]: 345.16. 
IR (vmax/cm
-1): 3023 (ArC-H); 1588, 1552 (ArC=C); 1371 (CH3); 1053 (C-O). 
4.6.7.  Synthesis of (E)-2-((4-nitrobenzylidene)amino)phenol (8g) 
 
4.6.7.1.  METHOD A 
Stirring time = 1 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a yellow solid (3.33 g, 98%). Rf (40% EtOAc/hexane) 
0.74. MP = 166 – 170 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.79 (1H, s, H7’), 8.34 (2H, d, J = 
8.6 Hz, H3’, H5’), 8.08 (2H, d, J = 8.6 Hz, H2’, H6’), 7.36 (1H, d, J = 8.0 Hz, H3), 7.31 – 7.22 (1H, m, 
H5), 7.18 (1H, s, OH), 7.06 (1H, d, J = 8.1 Hz, H6), 6.95 (1H, t, J = 7.7 Hz, H4). 13C NMR (126 
MHz, Chloroform-d): δ 153.81 (C-7’), 152.91 (C-1’), 149.36 (C-4’), 141.15 (C-1), 134.49 (C-2), 130.43 
(C-3’, C-5’), 129.28 (C-2’, C-6’), 124.14 (C-5), 120.34 (C-4), 115.87 (C-6), 115.63 (C-3). HRMS m/z: 
calculated for C13H10N2O3: 242.23, found: [M+H]: 243.08. IR (vmax/cm
-1): 3068 (ArC-H); 1588, 1513, 
(ArC=C); 1477&1374(N-O); 1103 (C-O).  
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4.6.8.  Synthesis of (E)-2-((2-bromo-4-methylbenzylidene)amino)phenol (8h) 
 
4.6.8.1.  METHOD A 
Stirring time = 6 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a light green solid (2.21 g, 76%). Rf (40% 
EtOAc/hexane) 0.81. MP = 102 – 108 °C.  1H NMR (500 MHz, Chloroform-d): δ 9.06 (1H, s, H7’), 
8.10 (1H, d, J = 8.0 Hz, H6’), 7.47 (1H, s, H3’), 7.34 (1H, d, J = 7.9 Hz, H5’), 7.21 (3H, m, H3, H5, 
OH ), 7.02 (1H, d, J = 8.0 Hz, H6), 6.92 (1H, t, J = 7.6 Hz, H4), 2.40 (3H, s, CH3). 
13C NMR (126 
MHz, Chloroform-d): δ 155.89 (C-7’), 152.46 (C-1), 143.65 (C-1’), 135.47 (C-4’), 133.81 (C-3’), 
131.61 (C-2), 129.23 (C-6’), 128.74 (C-5’), 128.56 (C-2’), 126.20 (C-5), 120.18 (C-4), 116.20 (C-6), 
115.08 (C-3), 21.24 (CH3). HRMS m/z: calculated for C14H12BrNO: 290.16, found: [M+H]: 291.07. IR 
(vmax/cm
-1): 3029 (ArC-H); 1588, 1514 (ArC=C); 1373 (CH3); 1103 (C-O); 731 (C-Br). 
4.6.9.  Synthesis of (E)-2-((3-bromobenzylidene)amino)phenol (8i) 
 
4.6.9.1.  METHOD A 
Stirring time = 6 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a light brown solid (2.57 g, 93%). Rf (40% 
EtOAc/hexane) 0.42. MP = 104 – 109 °C. 1H NMR (500 MHz, Chloroform-d):  δ 8.65 (1H, s, 
H7’), 8.11 (1H, s, H2’), 7.83 (1H, d, J = 7.8 Hz, H4’), 7.65 (1H, d, J = 8.0 Hz, H6’), 7.52 – 7.15 (4H, m, 
H3, H5, H6, H5’), 7.07 (1H, t, J = 8.1 Hz, H4), 6.96 (1H, s, OH). 13C NMR (126 MHz, Chloroform-
d): δ 155.13 (C-7’), 152.50 (C-1), 137.80 (C-1’), 134.93 (C-2’), 134.37 (C-2), 131.18 (C-4’), 130.34 (C-
5’), 129.47 (C-6’), 127.55 (C-3’), 123.12 (C-5), 120.16 (C-4), 115.85 (C-6), 115.27 (C-3). HRMS m/z: 
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calculated for C13H10BrNO: 276.13, found: [M+H]: 277.05. IR (vmax/cm
-1): 3038 (ArC-H); 1579, 1557 
(ArC=C); 1473 (CH3); 1089 (C-O); 733 (C-Br). 
4.6.10.  Synthesis of (E)-2-((3-methoxybenzylidene)amino)phenol (8j) 
 
4.6.10.1.  METHOD A 
Stirring time = 36 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a solid (1.54 g, 68%). Rf (40% EtOAc/hexane) 0.80. 
MP = 116 – 119 °C. 1H NMR (500 MHz, Chloroform-d): δ 9.07 (1H, s, H7’), 8.24 (1H, d, J = 2.3 
Hz, H6’), 7.52 (1H, dd, J = 8.8, 2.5 Hz, H5’), 7.31 (1H, d, J = 7.9 Hz, H3), 7.26 (1H, s, H2’), 7.24 (1H, 
s, OH), 7.19 (1H, t, J = 7.7 Hz, H5), 7.01 (1H, d, J = 8.0 Hz, H6), 6.90 (1H, t, J = 7.6 Hz, H4), 6.85 
(1H, d, J = 8.8 Hz, H4’), 3.91 (3H, s, OMe). 13C NMR (126 MHz, Chloroform-d): δ 158.53 (C-7’), 
152.49 (C-3’), 151.37 (C-1), 135.73 (C-1’), 135.24 (C-2), 129.85 (C-5’), 129.04 (C-5), 126.19 (C-4), 
120.05 (C-6’), 116.13 (C-6), 115.04 (C-3), 113.61 (C-4’), 113.13 (C-2’), 55.90 (OMe). HRMS m/z: 
calculated for C13H10BrNO: 227.26 found: [M+H]: 228.95. IR (vmax/cm
-1): 3003 (ArC-H); 1580, 1509, 
(ArC=C); 1120 (C-O).   
4.6.11.  Synthesis of (E)-2-((2-bromobenzylidene)amino)-4-methylphenol (8k) 
 
4.6.11.1.  METHOD A 
Stirring time = 8 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a green solid (1. 967 g, 68%). Rf (40% EtOAc/hexane) 
0.79. MP = 127 – 135 °C. 
 1H NMR (500 MHz, Chloroform-d): δ 9.08 (1H, s, H7’), 8.20 (1H, d, J = 
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7.4 Hz, H3’), 7.64 (1H, d, J = 8.0 Hz, H6’), 7.42 (1H, t, J = 7.5 Hz, H4’), 7.33 (1H, t, J = 8.0 Hz, H5’), 
7.15 (1H, s, H3), 7.04 (1H, d, J = 8.2 Hz, H5), 6.92 (1H, d, J = 8.2 Hz, H6), 2.26 (3H, s, CH3). 
13C 
NMR (126 MHz, Chloroform-d): δ 155.46 (C-7’), 150.36 (C-1’), 134.88 (C-1), 134.36 (C-3’), 133.43 
(C-4), 132.49 (C-2), 130.16 (C-6’), 129.52 (C-4’), 128.81 (C-5’), 127.73 (C-2’), 126.21 (C-5), 116.59 (C-
6), 114.88 (C-3), 20.81 (CH3). HRMS m/z: calculated for C14H12BrNO: 290.16, found: [M+H]: 291.07. 
IR (vmax/cm
-1): 3024 (ArC-H); 1580, 1558 (ArC=C); 1377 (CH3); 1114 (C-O); 733 (C-Br). 
4.6.12.  Synthesis of (E)-2-((2-chlorobenzylidene)amino)-4-methylphenol (8l) 
 
4.6.12.1.  METHOD A 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a solid (1.37 g, 56%). Rf (40% EtOAc/hexane) 0.86. 
MP = 117 – 120 °C. 1H NMR (500 MHz, Chloroform-d): δ 9.14 (1H, s, H7’), 8.22 (1H, d, J = 7.7 
Hz, H3’), 7.51 – 7.32 (3H, m, H4’, H5’, H6’), 7.15 (1H, s, OH), 7.03 (2H, d, J = 6.3 Hz, H5, H3), 6.92 
(1H, d, J = 8.2 Hz, H6), 2.33 (3H, s, CH3). 
13C NMR (126 MHz, Chloroform-d): δ 153.06 (C-7’), 
150.37 (C-1’), 136.18 (C-1), 134.98 (C-2’), 133.03 (C-4), 132.25 (C-2), 130.15 (C-3’), 130.13 (C-6’), 
129.50 (C-4’), 128.33(C-5’), 127.13 (C-5), 116.55 (C-6), 114.86 (C-3), 20.80 (CH3). HRMS m/z: 
calculated for C14H12ClNO: 245.70, found: [M+H]: 246.92. IR (vmax/cm
-1): 3026 (ArC-H); 1582, 1580 
(ArC=C); 1114 (C-O); 732 (C-Cl). 
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4.6.13.  Synthesis of (E)-4-methyl-2-((2-nitrobenzylidene)amino)phenol (8m) 
 
4.6.13.1.  METHOD A 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a solid (1.23 g, 48%). Rf (40% EtOAc/hexane) 0.70. 
MP = 125 – 127 °C. 1H NMR (500 MHz, Chloroform-d): δ 9.15 (1H, s, H7’), 8.27 (1H, d, J = 7.8 
Hz, H3’), 8.06 (1H, d, J = 8.1 Hz, H6’), 7.74 (1H, t, J = 7.6 Hz, H5’), 7.63 (1H, t, J = 7.7 Hz, H4’), 7.15 
(1H, s, OH), 7.07 (1H, d, J = 8.3 Hz, H5), 6.99 – 6.88 (2H, m, H3, H6), 2.32 (3H, s, CH3). 
13C NMR 
(126 MHz, Chloroform-d): δ 151.54 (C-7’), 150.63 (C-2’), 149.42 (C-1), 134.32 (C-1’), 133.40 (C-4), 
131.29 (C-6’), 130.92 (C-2), 130.65 (C-4’), 129.71 (C-5’), 129.48 (C-3’), 124.67 (C-5), 116.70 (C-6), 
115.15 (C-3), 20.75 (CH3). HRMS m/z: calculated for C14H12N2O3: 256.26, found: [M+H]: 257.09.  IR 
(vmax/cm
-1): 3044 (ArC-H); 1582, 1500 (ArC=C); 1086 (C-O). 
4.6.14.  Synthesis of (E)-2-((4-chlorobenzylidene)amino)phenol (8n) 
 
4.6.14.1.  METHOD A 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a light brown solid (2.14 g, 93%). Rf (40% 
EtOAc/hexane) 0.74. MP = 122 – 126 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.69 (1H, s, H7’), 
7.89 (2H, d, J = 8.4 Hz, H3’, H5’), 7.49 (2H, d, J = 8.4 Hz, H2’, H6’), 7.33 (1H, d, J = 7.9 Hz, H5), 
7.28 – 7.18 (2H, m, H3, OH), 7.05 (1H, d, J = 8.0 Hz, H6), 6.94 (1H, t, J = 7.6 Hz, H4). 13C NMR 
(126 MHz, Chloroform-d): δ 155.53 (C-7’), 152.39 (C-1), 137.71 (C-1’), 135.16 (C-4’), 134.34 (C-2), 
129.90 (C-3’, C-5’), 129.24 (C-2’, C-6’), 129.21 (C-5), 120.16 (C-4), 115.81 (C-6), 115.16 (C-3). HRMS 
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m/z: calculated for C13H10ClNO: 231.68, found: [M+H]: 232.05. IR (vmax/cm
-1): 3299 (ArC-H); 1583, 
1565 (ArC=C); 1095 (C-O); 752 (C-Cl). 
4.6.15.  Synthesis of (E)-2-((pyridin-4-ylmethylene)amino)phenol (8o) 
 
4.6.15.1.  METHOD A 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford an amber solid (1.88 g, 95%). Rf (40% EtOAc/hexane) 
0.21. MP = 174 – 176 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.77 (2H, d, J = 5.6 Hz, H3’, H5’), 
8.69 (1H, s, H7’), 7.75 (2H, d, J = 5.6 Hz, H2’, H6’), 7.34 (1H, d, J = 8.0 Hz, H5), 7.25 (2H, m, H3, 
OH), 7.04 (1H, d, J = 8.1 Hz, H6), 6.93 (1H,  t, J = 7.7 Hz, H4). 13C NMR (126 MHz, Chloroform-
d): δ 154.33 (C-7’), 152.87 (C-3’, C-5’), 150.69 (C-1’), 142.40 (C-1), 134.43 (C-2), 130.41 (C-6’, C-2’), 
122.07 (C-5), 120.29 (C-4), 115.98 (C-6), 115.63 (C-3). HRMS m/z: calculated for C12H10N2O: 198.22, 
found: [M+H]: 199.09. IR (vmax/cm
-1): 3043 (ArC-H); 1577, 1558 (ArC=C); 1365 (C-N); 1088 (C-O). 
4.6.16.  Synthesis of (E)-2-((4-(dimethylamino)benzylidene)amino)phenol (8p) 
 
4.6.16.1.  METHOD A 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a solid (1.73 g, 72%). Rf (40% EtOAc/hexane) 0.46. 
MP = 123 – 124 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.55 (1H, s, H7’), 7.80 (2H, d, J = 8.7 
Hz, H2’, H6’), 7.26-7.24 (1H, m, H3), 7.12 (1H, t, J = 7.7 Hz, H3), 6.99 (1H, d, J = 8.0 Hz, H6), 6.88 
(1H, t, J = 7.6 Hz, H4), 6.74 (2H, d, J = 8.7 Hz, H3’, H5’), 3.07 (6H, s, 2 x CH3 ). 
13C NMR (126 
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MHz, Chloroform-d): δ 157.15 (C-7’), 152.70 (C-4’), 151.89 (C-1), 136.65 (C-2), 130.55 (C-1’), 127.36 
(C-2’, C-6’), 124.05 (C-5), 119.93 (C-4), 115.58 (C-6), 114.38 (C-5), 111.57 (C-3’, C-5’), 40.14 (2 x CH3). 
HRMS m/z: calculated for C15H16N2O: 240.30, found: [M+H]: 241.33. IR (vmax/cm
-1): 3004 (ArC-H); 
1584, 1536 (ArC=C); 1482 (CH3); 1369 (C-N); 1087 (C-O). 
4.6.17.  Synthesis of 2,2'-((1E,1'E)-(1,4-
phenylenebis(methanylylidene))bis(azanylylidene))diphenol (8q) 
 
4.6.17.1.  METHOD A 
2-aminophenol (2 equiv), Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 
mL) to remove any excess starting material (confirmed by TLC) to afford a gold solid (3.09 g, 98%). Rf 
(40% EtOAc/hexane) 0.48.  MP = 198 – 224 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.75 (2H, 
s, H7’, H7’’), 8.03 (4H, s, H2’, H3’, H5’, H6’), 7.34 (2H, d, J = 7.9 Hz, H3, H3’’), 7.26 (2H, d, J = 3.0 
Hz, OH), 7.23 (2H, t, J = 7.7 Hz, H5, H5’’), 7.04 (2H, d, J = 8.1 Hz, H6, H6’’), 6.93 (2H, t, J = 7.6 Hz, 
H4, H4’’). 13C NMR (126 MHz, Chloroform-d): δ 155.73 (C-7’, C-7’’), 152.63 (C-1, C-1’’), 138.49 (C-
1’, C-4’), 135.17 (C-2, C-2’’), 129.54 (C-2’, C-3’, C-5’, C-6’), 129.15 (C-5, C-5’’), 120.20 (C-4, C-4’’), 
115.82 (C-6, C-6’’), 115.25 (C-5, C-5’’). HRMS m/z: calculated for C20H16N2O2: 316.35, found: 
[M+H]: 317.13. IR (vmax/cm
-1): 3045 (ArC-H); 1587 (ArC=C); 1095 (C-O). 
4.6.18.  Synthesis of (E)-2-((4-chlorobenzylidene)amino)-4-methylphenol (8r) 
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4.6.18.1.  METHOD A 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a gold solid (2.32 g, 94%). Rf (40% EtOAc/hexane) 
0.76. MP = 88 – 90 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.64 (1H, s, H7’), 7.84 (2H, d, J = 
8.3 Hz, H3’, H5’), 7.46 (2H, d, J = 8.3 Hz, H2’, H6’), 7.10 (1H, s, H3), 7.02 (1H, d, J = 8.2 Hz, H5), 
6.91 (1H, d, J = 8.2 Hz, H6), 2.32 (3H, s, CH3).
 13C NMR (126 MHz, Chloroform-d): δ 155.15 (C-7’), 
150.16 (C-1), 137.58 (C-1’), 134.76 (C-4’), 134.44 (C-4), 129.84 (C-2), 129.82 (C-3’, C-5’), 129.41 (C-2’, 
C-6’), 129.18 (C-5), 116.25 (C-6), 114.82 (C-3), 20.79 (CH3).  HRMS m/z: calculated for C14H12ClNO: 
245.70, found: [M+H]: 246.07. IR (vmax/cm
-1): 3302 (ArC-H); 1588, 1587 (ArC=C); 1099 (C-O); 718 
(C-Cl). 
4.6.19.  Synthesis of (E)-2-((2-bromobenzylidene)amino)phenol (8s) 
 
4.6.19.1.  METHOD A 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a grey solid (2.58 g, 94%). Rf (40% EtOAc/hexane) 
0.71. MP = 96 – 102 °C.  1H NMR (500 MHz, Chloroform-d): δ 9.10 (1H, s, H7’), 8.21 (1H, d, J = 
7.1 Hz, H3’), 7.64 (1H, d, J = 7.5 Hz, H4’), 7.52 – 7.17 (5H, m, H3, H5, H5’, H6’, NH), 7.05 (1H, d, J 
= 7.6 Hz, H6), 6.95 (1H, t, J = 6.8 Hz, H4). 13C NMR (126 MHz, Chloroform-d): δ 155.83 (C-7’), 
152.54 (C-1’), 135.29 (C-1), 134.23 (C-3’), 133.41 (C-2), 132.54 (C-6’), 129.49 (C-4’), 128.81 (C-5’), 
127.71 (C-2’), 126.23 (C-5), 120.20 (C-4), 116.26 (C-6), 115.21 (C-3). HRMS m/z: calculated for 
C13H10BrNO: 276.13, found: [M+H]: 277.00. IR (vmax/cm
-1): 3083 (ArC-H); 1580, 1558 (ArC=C); 
1098 (C-O); 702 (C-Br). 
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4.6.20.  Synthesis of 2-amino-3H-phenoxazin-3-one (8t) 
 
4.6.20.1.  METHOD K 
Stirring time = 24 h. Purification by flash chromatography (silica/EtOAc-hexane, 1:4) to afford a 
marron solid (1.14 g, 54 %). Rf (40% EtOAc/hexane) 0.44. MP = 248 – 250 °C. 
1H NMR (500 
MHz, Chloroform-d): δ 7.76 (1H, d, J = 7.9 Hz, H5), 7.44 (1H, t, J = 7.4 Hz, H3), 7.41 – 7.31 (2H, 
m, H2, H4), 6.48 (1H, s, H11), 6.42 (1H, s, H8), 5.11 (2H, s, NH2). 13C NMR (126 MHz, 
Chloroform-d): δ 180.34 (C-10), 149.43 (C-9), 148.74 (C-7), 145.72 (C-12), 142.80 (C-1), 133.99 (C-6), 
129.59 (C-5), 128.82 (C-3), 125.29 (C-4), 116.05 (C-2), 104.16 (C-8), 100.89 (C-11). HRMS m/z: 
calculated for C12H8N2O2: 212.20, found: [M+H]: 213.06. IR (vmax/cm
-1): 3407 (N-H); 3057 (ArC-H); 
1805 (C=O); 1554 (ArC=C); 1113 (C-O). 
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4.7.  Synthesis of benzimidazoles 
The following methods were used for the synthesis of benzimidazoles 
Method L 
A mixture of o-phenylenediamine (10.0 mmol, 1 equiv) and benzaldehyde derivative (20.0 mmol, 2 
equiv) in acetonitrile (10.0 mL) and acetate buffer (10.0 mL, pH 4.5) was stirred at room temperature 
for 5 minutes. Suberase® (2.0 mL) was added to the mixture and the contents were stirred until 
reaction completes (monitored by TLC). The product precipitates from the solution as the reaction 
proceeds and after completion; the product was extracted with ethyl acetate (30.0 mL) and water (3 x 
20.0 mL) and concentrated on a rotary evaporator. The product was washed several times with cold 
acetonitrile (3 x 20.0 mL) to remove any excess starting material.  
Method M 
The same as Method L, except that methanol (2.0 mL) was used instead of acetonitrile.  
Method N 
The same as Method L, except that ethanol (4.0 mL) was used instead of acetonitrile.  
Method O 
The same as Method L, except that DMF (10.0 mL) was used instead of acetonitrile.  
Method P 
A repetition of Method L using Denilite® II Base (0.085 g) and Novoprime Base 268 (0.105 g) 
laccases instead of Suberase® (2.0 mL). 
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4.7.1.  Synthesis of 2-(2-methoxyphenyl)-1H-benzimidazole (11a) 
 
4.7.1.1.  METHOD L 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (1.38 g, 62%). Rf (40% EtOAc/hexane) 
0.38. 
4.7.1.2.  METHOD M 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (1.32 g, 59%). Rf (40% EtOAc/hexane) 
0.38. 
4.7.1.3.  METHOD O 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (1.61 g, 72%). Rf (40% EtOAc/hexane) 
0.38. 
4.7.1.4.  METHOD P 
Novoprime Base 268 (0.105 g), Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a brown solid (1.55 g, 
69%). Rf (40% EtOAc/hexane) 0.38.  MP = 178 – 180 °C. 
1H NMR (500 MHz, DMSO-d6): δ 12.11 
(1H, s, NH), 8.33 (1H, d, J = 7.6 Hz, H6’), 7.63 (2H, dd, J = 16.6, 7.5 Hz, H5, H8), 7.48 (1H, t, J = 7.8 
Hz, H4’), 7.24 (1H, d, J = 8.3 Hz, H7), 7.19 (2H, t, J = 6.5 Hz, H3’, H5’), 7.12 (1H, t, J = 7.5 Hz, H6), 
4.03 (3H, s, OMe). 13C NMR (126 MHz, DMSO-d6): δ 157.25 (C-2), 149.43 (C-2’), 143.20 (C-9), 
135.19 (C-4), 131.70 (C-6’), 130.23 (C-4’), 122.51 (C-5’), 121.96 (C-1’), 121.34 (C-3’), 118.89 (C-7), 
  92 
118.63 (C-6), 112.58 (C-8), 112.38 (C-5), 56.25 (OMe). IR (vmax/cm
-1): 3043 (ArC-H); 1619 (C=N); 
1584, 1537 (ArC=C); 1306 (C-O). 
4.7.2.  Synthesis of 2-(2,5-dimethoxyphenyl)-1H-benzimidazole (11c) 
 
4.7.2.1.  METHOD M 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (0.253 g, 10%). Rf (40% EtOAc/hexane) 
0.38.  
4.7.2.2.  METHOD N 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (0.677 g, 25%). Rf (40% EtOAc/hexane) 
0.38. 
4.7.2.3.  METHOD P 
Novoprime Base 268 (0.105 g), stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a white solid (1.93 g, 
76%). Rf (40% EtOAc/hexane) 0.38. MP = 224 – 226 °C.
 1H NMR (500 MHz, DMSO-d6): δ 12.09 
(1H, s, NH), 7.87 (1H, d, J = 2.8 Hz, H3’), 7.63 (2H, dd, J = 19.0, 7.2 Hz, H5, H8), 7.19 (3H, m, H6, 
H7, H6’), 7.05 (1H, dd, J = 9.0, 2.9 Hz, H4’), 3.98 (3H, s, OMe), 3.81 (3H, s, OMe). 13C NMR (126 
MHz, DMSO-d6): δ 153.69 (C-2), 151.56 (C-5’), 149.21 (C-2’), 143.10 (C-9), 135.23 (C-4), 122.61 (C-
7), 122.04 (C-6), 118.92 (C-1’), 117.60 (C-4’), 114.10 (C-5, C-8), 113.96 (C-2’), 112.48 (C-6’), 56.65 
(OMe-5’), 56.03 (OMe-2’). IR (vmax/cm
-1): 2937 (ArC-H); 1619 (C=N); 1523, 1492 (ArC=C); 1301 (C-
O). 
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4.7.3.  Synthesis of 2-(3,4-dimethoxyphenyl)-1H-benzimidazole (11d) 
 
4.7.3.1.  METHOD L 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (1.48 g, 59%). Rf (60% EtOAc/hexane) 
0.43. MP = 230 – 232 °C. 1H NMR (300 MHz, Chloroform-d): δ 8.28 – 7.99 (1H, m, H8), 7.74 – 
7.43 (3H, m, H5, H2’, H6’), 7.22 (1H, d, J = 8.2 Hz, H7), 7.14 (1H, dd, J = 8.3, 3.5 Hz, H6), 7.08 – 
6.89 (1H, m, H5’), 5.75 (1H, s, NH), 4.85 – 3.50 (6H, m, 2 x OMe). 13C NMR (126 MHz, DMSO-
d6): δ 153.70 (C-2), 150.56 (C-3’), 149.39 (C-4’), 143.09 (C-9), 136.51 (C-4), 129.86 (C-1’), 122.97 (C-7), 
122.85 (C-6), 122.51 (C-6’), 118.95 (C-8), 118.53 (C-5), 112.32 (C-2’), 111.38 (C-5’), 56.10 (2 x OMe): 
IR (vmax/cm
-1): 2940 (ArC-H); 1606 (C=N); 1588, 1501, (ArC=C); 1320 (C-O). 
4.7.3.2.  METHOD M 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (0.864 g, 34%). Rf (60% EtOAc/hexane) 
0.42.  
4.7.3.3.  METHOD O 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (1.71 g, 67%). Rf (60% EtOAc/hexane) 
0.42. 
4.7.3.4.  METHOD P 
Denilite® II Base (0.085 g), stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a yellow oil (1.45 g, 
57%). Rf (60% EtOAc/hexane) 0.42. 
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4.7.3.5.  METHOD P 
Novoprime Base 268 (0.105 g), stirring time = 8 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a brown solid (1.97 g, 
78%). Rf (60% EtOAc/hexane) 0.42. 
4.7.4.  Synthesis of 2-phenyl-1H-benzimidazole (11e) 
 
4.7.4.1.  METHOD P 
Novoprime Base 268 (0.105 g), Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a brown solid (1.77 g, 
92%). Rf (40% EtOAc/hexane) 0.42. MP = 290 – 293 °C. 
1H NMR (500 MHz, DMSO-d6): δ 12.89 
(1H, s, NH), 8.19 (2H, d, J = 7.5 Hz, H2’, H6’), 7.68 (1H, d, J = 7.6 Hz, H8), 7.53 (4H, m, H5, H7, 
H3’, H5’), 7.21 (2H, dt, J = 15.6, 6.6 Hz, H6, H4’).  13C NMR (126 MHz, DMSO-d6): δ 151.69 (C-2), 
144.29 (C-9, C-4), 135.47 (C-1’), 130.65 (C-4’), 130.29 (C-3’, C-5’), 129.40 (C-2’), 126.90 (C-6’), 122.99 
(C-7), 122.12 (C-6), 119.34 (C-8), 111.78 (C-5). IR (vmax/cm
-1): 3047 (ArC-H); 2921 (N-H); 1622 
(C=N); 1559, 1542, (ArC=C). 
4.7.5.  Synthesis of 2-(2-chlorophenyl)-1H-benzimidazole (11f) 
 
4.7.5.1.  METHOD P 
Novoprime Base 268 (0.105 g), stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a brown solid (2.14 g, 
94%). Rf (40% EtOAc/hexane) 0.58. MP = 231 – 234 °C. 
1H NMR (500 MHz, DMSO-d6): δ 12.71 
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(1H, s, NH), 7.92 (1H, d, J = 7.1 Hz, H6’), 7.78 – 7.46 (5H, m, H5, H8, H3’, H4’, H5’), 7.25 (2H, d, J 
= 6.8 Hz, H6, H7). 13C NMR (126 MHz, DMSO-d6): δ 149.56 (C-2), 143.69 (C-1’), 135.13 (C-9), 
132.54 (C-4), 132.11 (C-2’), 131.65 (C-4’), 130.81 (C-3’), 130.46 (C-6’), 127.88 (C-5’), 123.18 (C-7), 
122.17 (C-6), 119.56 (C-8), 112.17 (C-5). IR (vmax/cm
-1): 3045 (ArC-H); 1622 (C=N); 1569, 1539, 
(ArC=C); 700 (C-Cl). 
4.7.6.  Synthesis of 2-(4-chlorophenyl)-1H-benzimidazole (11g) 
 
4.7.6.1.  METHOD P 
Novoprime Base 268 (0.105 g), Stirring time = 4 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a brown solid (2.02 g, 
88%). Rf (40% EtOAc/hexane) 0.42. MP = 286 – 289 °C. 
1H NMR (500 MHz, DMSO-d6): δ 12.98 
(1H, s, NH), 8.20 (2H, d, J = 8.4 Hz, H2’, H6’), 7.64 (4H, m, H5, H8, H3’, H5’), 7.22 (2H, d, J = 6.7 
Hz, H6, H7). 13C NMR (126 MHz, DMSO-d6): δ 149.56 (C-2), 143.69 (C-9), 135.13 (C-4), 132.54 (C-
4’), 132.11 (C-1’), 131.65 (C-3’), 130.81 (C-5’), 130.46 (C-2’), 127.88 (C-6’), 123.18 (C-7), 122.17 (C-6), 
119.56 (C-8), 112.17 (C-5). IR (vmax/cm
-1): 3052 (ArC-H); 1622 (C=N); 1588, 1540, (ArC=C); 727 (C-
Cl). 
4.7.7.  Synthesis of 2-(2-nitrophenyl)-1H-benzimidazole (11h) 
 
4.7.7.1.  METHOD P 
Novoprime Base 268 (0.105 g), Stirring time = 8 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford an orange-brown solid 
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(1.33 g, 56%). Rf (40% EtOAc/hexane) 0.22. MP = 191 – 193 °C. 
1H NMR (500 MHz, DMSO-d6): 
δ 12.21 (1H, s, NH), 7.21 (1H, d, J = 8.0 Hz, H6’), 7.15 (1H, d, J = 7.7 Hz, H3’), 7.04 (1H, t, J = 7.6 
Hz, H5’), 6.94 (1H, t, J = 7.7 Hz, H4’), 6.79 (2H, s, H5, H8), 6.43 (2H, s, H6, H7). 13C NMR (126 
MHz, DMSO-d6): δ 149.44 (C-2), 147.77 (C-2’), 133.11 (C-4, C-9), 131.39 (C-5’, C-6’), 131.36 (C-1’, 
C-4’), 124.76 (C-6, C-7, C-3’), 124.71 (C-5, C-8). IR (vmax/cm
-1): 3064 (ArC-H); 1625 (C=N); 1573, 
1524, (ArC=C). 
4.7.8.  Synthesis of 2-(pyridin-4-yl)-1H-benzimidazole (11i) 
 
4.7.8.1.  METHOD P 
Novoprime Base 268 (0.105 g), Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a brown solid (1.69 g, 
60%). Rf (40% EtOAc/hexane) 0.13. MP = 211 – 214 °C. 
1H NMR (500 MHz, DMSO-d6): δ 13.23 
(1H, s, NH), 8.76 (2H, d, J = 4.9 Hz, H3’, H5’), 8.10 (2H, d, J = 4.8 Hz, H2’, H6’), 7.66 (2H, d, J = 
68.5 Hz, H5, H8), 7.50 – 7.02 (2H, m, H6, H7). 13C NMR (126 MHz, DMSO-d6): δ 150.97 (C-2), 
149.24 (C-3’, C-5’), 144.13 (C-1’), 137.60 (C-9), 135.49 (C-4), 124.03 (C-6, C-7), 122.73 (C-2’), 120.79 
(C-6’), 119.93 (C-8), 112.27 (C-5). IR (vmax/cm
-1): 3051 (ArC-H); 2877(N-H); 1665 (C=N); 1562, 
1537, (ArC=C) 
4.7.9.  Synthesis of 2-(3-nitrophenyl)-1H-benzimidazole (11j) 
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4.7.9.1.  METHOD P 
Novoprime Base 268 (0.105 g), Stirring time = 4 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a brown solid (2.26 g, 
95%). Rf (40% EtOAc/hexane) 0.43. MP = 202 – 205 °C. 
1H NMR (500 MHz, DMSO-d6): δ 13.27 
(1H, s, NH), 9.02 (1H, s, H2’), 8.62 (1H, d, J = 7.7 Hz, H6’), 8.33 (1H, d, J = 8.2 Hz, H4’), 7.86 (1H, t, 
J = 8.0 Hz, H5’), 7.66 (2H, d, J = 50.7 Hz, H5, H8), 7.26 (2H, d, J = 6.7 Hz, H6, H7). 13C NMR (126 
MHz, DMSO-d6): δ 147.43 (C-2), 146.75 (C-3’), 130.84 (C-4, C-9), 130.12 (C-6’), 129.04 (C-1’, C-5’), 
122.55 (C-4’), 119.20 (C-6, C-7, C-2’), 116.36 (C-5, C-8). IR (vmax/cm
-1): 3098 (ArC-H); 1623 (C=N); 
1588, 1517 (ArC=C). 
4.7.10.  Synthesis of 4-(1H-benzimidazol-2-yl)-N,N-dimethylaniline (11k) 
 
4.7.10.1.  METHOD P 
Novoprime Base 268 (0.105 g), Stirring time = 8 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford an orange solid (1.52 g, 
64%). Rf (40% EtOAc/hexane) 0.17. MP = 201 – 202 °C. 
1H NMR (500 MHz, DMSO-d6): δ 8.14 
(1H, s, NH), 7.99 (2H, d, J = 8.7 Hz, H2’, H6’), 7.48 (2H, d, J = 9.2 Hz, H5, H8), 7.14 (2H, d, J = 9.2 
Hz, H6, H7), 6.83 (2H, d, J = 8.7 Hz, H3’, H5’), 3.00 (6H, s, 2 x N-CH3). 
13C NMR (126 MHz, 
DMSO-d6): δ 163.47 (C-2), 152.72 (C-4’), 151.74 (C-9, C-4), 128.02 (C-2’, C-6’), 121.80 (C-6, C-7), 
117.83 (C-5, C-8, C-1’), 112.32 (C-3’, C-5’). IR (vmax/cm
-1): 2887 (ArC-H); 2773 (N-H); 1637 (C=N); 
1593, 1504 (ArC=C). 
 
 
 
  98 
4.7.11.  Synthesis of (E)-5-bromo-N1-(4-(dimethylamino)benzylidene)benzene-1,2-diamine 
(11l) 
 
4.7.11.1.  METHOD P 
Novoprime Base 268 (0.105 g), Stirring time = 12 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a brown solid (3.12 g, 
98%). Rf (40% EtOAc/hexane) 0.98. MP = 151 – 153 °C. 
1H NMR (500 MHz, DMSO-d6): δ 8.43 
(1H, s, H7’), 7.78 (2H, d, J = 8.5 Hz, H2’, H6’), 6.95 (1H, d, J = 8.3 Hz, H6), 6.85 (1H, s, H3), 6.77 
(2H, d, J = 8.5 Hz, H3’, H5’), 6.65 (1H, d, J = 8.3 Hz, H5), 5.31 (2H, s, NH), 3.00 (6H, s, N-CH3). 
13C 
NMR (126 MHz, DMSO-d6): δ 157.60 (C-7’), 152.76 (C-4’), 145.55 (C-1, C-2), 136.21 (C-1’), 130.76 
(C-2’, C-6’), 124.66 (C-5), 119.01 (C-6), 118.80 (C-3), 116.48 (C-3’, C-5’), 111.92 (C-4). IR (vmax/cm
-1): 
2889 (ArC-H); 1589 (N-H); 1547, 1522 (ArC=C). 
4.7.12.  Synthesis of 2-(4-nitrophenyl)-1H-benzimidazole (11m) 
 
4.7.12.1.  METHOD P 
Novoprime Base 268 (0.105 g), Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a brown solid (2.27 g, 
95%). Rf (40% EtOAc/hexane) 0.52. MP = 320 °C. 
1H NMR (500 MHz, DMSO-d6): δ 13.28 (1H, s, 
NH), 8.42 (4H, s, H2’, H3’, H5’, H6’), 7.74 (1H, d, J = 7.6 Hz, H8), 7.59 (1H, d, J = 7.6 Hz, H5), 7.28 
(2H, m, H6, H7). 13C NMR (126 MHz, DMSO-d6): δ 149.48 (C-2), 148.30 (C-4’), 144.32 (C-1’), 
136.53 (C-9), 135.71 (C-4), 127.88 (C-2’, C-6’), 124.79 (C-3’, C-5’), 124.07 (C-7), 122.80 (C-6), 119.94 
(C-8), 112.28 (C-5). IR (vmax/cm
-1): 2748 (ArC-H); 1604 (C=N); 1513, 1433 (ArC=C). 
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4.7.13.  Synthesis of 2-(3,4,5-trimethoxyphenyl)-1H-benzoimidazole (11n) 
 
4.7.13.1.  METHOD P 
Novoprime Base 268 (0.105 g), stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a white solid (2.53 g, 
89%). Rf (40% EtOAc/hexane) 0.19. MP = 258-262 °C. 
 1H NMR (500 MHz, DMSO-d6): δ 12.82 
(1H, s, NH), 7.66 (1H, d, J = 7.8 Hz, H8), 7.55-7.53 (3H, m, H5, H6, H7), 7.20 (2H, p, J = 7.0 Hz, 
H2’, H6’), 3.91 (6H, s, 2 x OMe), 3.74 (3H, s, OMe). 13C NMR (126 MHz, DMSO-d6): δ 153.69 (C-
2), 151.68 (C-3’, C-5’), 144.22 (C-9), 139.38 (C-4), 135.44 (C-4’), 125.95 (C-1’), 122.89 (C-7), 122.09 (C-
6), 119.17 (C-5), 111.61 (C-8), 104.30 (C-2’, C-6’), 60.62 (OMe), 56.53 (2 x OMe). IR (vmax/cm
-1): 
2952 (ArC-H); 1589 (C=N); 1498, 1482 (ArC=C); 1311 (C-O).  
4.7.14.  Synthesis of 2-(4-methoxyphenyl)-1H-benzimidazole (11o) 
 
4.7.14.1.  METHOD P 
Novoprime Base 268 (0.105 g), Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a light brown solid 
(1.53 g, 68%). Rf (40% EtOAc/hexane) 0.31. MP = 226 – 228 °C. 
1H NMR (500 MHz, DMSO-d6): 
δ 12.73 (1H, s, NH), 8.12 (2H, d, J = 8.6 Hz, H2’, H6’), 7.56 (2H, d, J = 52.8 Hz, H5, H8), 7.20 – 7.14 
(2H, m, H6, H7), 7.11 (2H, d, J = 8.6 Hz, H3’, H5’), 3.84 (3H, s, OMe). 13C NMR (126 MHz, 
DMSO-d6): δ 161.07 (C-2), 151.82 (C-4’), 144.37 (C-9), 135.44 (C-4), 128.48 (C-2’, C-6’), 123.19 (C-7), 
122.49 (C-6), 121.98 (C-8), 121.91 (C-5), 118.96, 114.84 (C-3’, C-5’), 111.48 (C-1’), 55.80 (OMe). IR 
(vmax/cm
-1): 3044 (ArC-H); 1621 (C=N); 1583, 1500 (ArC=C); 1317 (C-O). 
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4.7.15.  Synthesis of (N1,N1'E,N1,N1'E)-N1,N1'-(1,4-
phenylenebis(methanylylidene))bis(benzene-1,2-diamine) (11p) 
 
4.7.15.1.  METHOD P 
o-phenylenediamine (2 equiv), Novoprime Base 268 (0.105 g), Stirring time = 12 h. Purification by 
washing with cold acetonitrile (3 x 20.0 mL) to remove any excess starting material (confirmed by 
TLC) to afford an orange solid (3.08 g, 98%). Rf (40% EtOAc/hexane) 0.63. MP = 298 – 300 °C. 
1H 
NMR (500 MHz, DMSO-d6): δ 8.73 (2H, s, H7’, H7’’), 8.10 (4H, s, H2’, H3’, H5’, H6’), 7.18 (2H, d, 
J = 7.8 Hz, H6, H6’’), 6.99 (2H, t, J = 7.6 Hz, H5, H5’’), 6.74 (2H, d, J = 7.9 Hz, H3, H3’’), 6.58 (2H, t, 
J = 7.5 Hz, H4, H4’’), 5.25 (4H, s, NH). 13C NMR (126 MHz, DMSO-d6): δ 155.94 (C-7’, C-7’’), 
144.70 (C-1’, C-4’), 135.41 (C-1, C-2, C-1’’, C-2’’), 129.25 (C-2’, C-3’, C-5’, C-6’), 128.39 (C-5, C-5’’), 
117.41 (C-4, C-4’’), 116.62 (C-6, C-6’’), 115.28 (C-3, C-3’’). IR (vmax/cm
-1): 3085 (ArC-H); 2883 (N-H); 
1592, 1488 (ArC=C). 
4.7.16.  Synthesis of 1-(2-methoxybenzyl)-2-(2-methoxyphenyl)-1H-benzimidazole (12a) 
 
4.7.16.1.  METHOD M 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford an orange solid (0.689 g, 20%). Rf (40% 
EtOAc/hexane) 0.34. MP = 148 – 152 °C.  1H NMR (500 MHz, DMSO-d6): δ 7.67 (1H, d, J = 7.7 
Hz, H6’), 7.52 (1H, t, J = 7.8 Hz, H5’), 7.42 (1H, d, J = 7.4 Hz, H7’’), 7.36 (1H, d, J = 7.1 Hz, H3’), 
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7.27 – 7.12 (4H, m, H6, H7, H8, H4’), 7.07 (1H, t, J = 7.4 Hz, H6’’), 6.92 (1H, d, J = 8.2 Hz, H5), 6.75 
(1H, t, J = 7.4 Hz, H5’’), 6.58 (1H, d, J = 7.4 Hz, H4’’), 5.21 (2H, s, H1’’), 3.67 (6H, s, OMe). 13C 
NMR (126 MHz, DMSO-d6): δ 157.53 (C-3’’), 156.83 (C-2’), 152.31 (C-2), 143.35 (C-4), 135.68 (C-
9), 132.39 (C-6’), 132.02 (C-4’), 129.17 (C-7’’), 127.94 (C-5’’), 124.64 (C-2’’), 122.66 (C-7), 122.03 (C-6), 
120.98 (C-5’), 120.57 (C-6’’), 120.00 (C-1’), 119.54 (C-8), 111.96 (C-5), 111.33 (C-3’), 111.16 (C-4’’), 
55.75 (OMe), 55.73 (OMe), 43.25 (C-1’’). IR (vmax/cm
-1): 3063 (ArC-H); 1603 (C=N); 1582, 1518; 
(ArC=C); 1327 (C-O). 
4.7.16.2.  METHOD N 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (0.447 g, 13%). Rf (40% EtOAc/hexane) 
0.34. 
4.7.17.  Synthesis of 3-(1-(3-hydroxybenzyl)-1H-benzoimidazol-2-yl)phenol (12b) 
 
4.17.1.  METHOD L 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (2.58 g, 82%). Rf (40% EtOAc/hexane) 
0.23. MP = 246 – 249 °C. 1H NMR (500 MHz, DMSO-d6): δ 9.77 (1H, d, J = 30.8 Hz, H6’), 9.43 
(1H, s, H2’), 7.73 (1H, d, J = 7.7 Hz, H8), 7.39 (1H, d, J = 7.5 Hz, H5), 7.33 (1H, q, J = 7.7 Hz, H5’), 
7.23 (3H, td, J = 17.7, 16.0, 8.7 Hz, H6, H7, H6’’), 7.17 – 7.06 (2H, m, OH), 6.95 (1H, d, J = 8.1 Hz, 
H7’’), 6.65 (1H, d, J = 8.0 Hz, H5’’), 6.50 (1H, d, J = 7.5 Hz, H4’), 6.40 (1H, s, H3’’), 5.49 (2H, s, H1’’). 
13C NMR (126 MHz, DMSO-d6): δ 156.09 (C-3’), 155.91 (C-4’’), 151.69 (C-2), 140.98 (C-4), 136.71 
(C-9, C-2’’), 134.25 (C-1’), 129.58 (C-5’), 128.19 (C-6’’), 120.96 (C-7), 120.52 (C-6), 117.87 (C-6’), 
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117.55 (C-7’’), 115.28 (C-8), 114.99 (C-5), 114.38 (C-4’), 112.82 (C-3’’), 111.07 (C-2’), 109.45 (C-5’’), 
45.81 (C-1’’).  
4.7.17.2.  METHOD N 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (3.06 g, 97%). Rf (40% EtOAc/hexane) 
0.23 
4.7.17.3.  METHOD O 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (3.10 g, 98%). Rf (40% EtOAc/hexane) 
0.23. 
4.7.17.4.  METHOD P 
Novoprime Base 268 (0.105 g), stirring time = 4 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a brown solid (2.72 g, 
86%). Rf (40% EtOAc/hexane) 0.23. 
4.7.18.  Synthesis of 1-(2,5-dimethoxybenzyl)-2-(2,5-dimethoxyphenyl)-1H-benzimidazole 
(12c) 
 
4.7.18.1.  METHOD L 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford an oil (2.25 g, 56%). Rf (40% EtOAc/hexane) 0.36. 
1H 
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NMR (500 MHz, DMSO-d6): δ 7.73 – 7.57 (1H, m, H6’), 7.48 – 7.32 (1H, m, H8), 7.28 – 7.14 (2H, 
m, H3’, H4’), 7.12 (2H, d, J = 9.3 Hz, H4’’, H5’’), 7.02 – 6.85 (1H, m, H7), 6.85 (1H, d, J = 8.9 Hz, 
H5), 6.75 (1H, dd, J = 8.9, 2.7 Hz, H6), 6.15 (1H, s, H7’’), 5.19 (2H, s, H1’’), 3.74 – 3.45 (12H, m, 4 x 
OMe). 13C NMR (126 MHz, DMSO-d6): δ 153.42 (C-2), 153.32 (C-5’), 151.90 (C-6’’), 151.58 (C-3’’), 
151.01 (C-2’), 143.22 (C-4), 135.63 (C-9), 125.80 (C-2’’), 122.76 (C-7), 122.10 (C-6), 120.61 (C-8), 
119.56 (C-5), 117.48 (C-1’), 117.10 (C-4’), 114.80 (C-7’’), 113.23 (C-3’), 113.00 (C-6’), 112.19 (C-5’’), 
111.37 (C-4’’), 56.22 (OMe-5’), 56.04 (OMe-6’’), 55.68 (OMe-3’’), 55.37 (OMe-2’), 43.26 (C-1’’).  
4.7.18.2.  METHOD M 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford an oil (3.64 g, 90%). Rf (40% EtOAc/hexane) 0.36. 
 
4.7.18.3.  METHOD N 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford an oil (2.82 g, 70%). Rf (40% EtOAc/hexane) 0.36. 
4.7.18.4.  METHOD O 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford an oil (3.79 g, 94%). Rf (40% EtOAc/hexane) 0.36. 
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4.7.19.  Synthesis of 1-(3,4-dimethoxybenzyl)-2-(3,4-dimethoxyphenyl)-1H-benzimidazole 
(12d) 
 
4.7.19.1.  METHOD L 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a yellow oil (1.45 g, 36%). Rf (60% EtOAc/hexane) 
0.21. 1H NMR (500 MHz, DMSO-d6): δ 7.88 (1H, s, H2’), 7.71 (1H,  d, J = 7.9 Hz, H6’), 7.53 (1H, 
d, J = 7.8 Hz, H8), 7.34 – 7.16 (3H, m, H5, H6, H7), 6.91 – 6.79 (2H, m, H5’, H6’’), 6.74 (1H, s, H3’’), 
6.62 (1H, d, J = 16.3 Hz, H7’’), 5.90 (2H, m, H1’’), 3.88 – 3.57 (12H, m, 4 x OMe). 13C NMR (126 
MHz, DMSO-d6): δ 153.71 (C-2), 150.59 (C-3’), 149.41 (C-4’), 149.36 (C-4’’), 149.18 (C-5’’), 148.60 
(C-4), 143.10 (C-9), 129.87 (C-1’), 122.99 (C-7), 122.85 (C-6), 122.16 (C-2’’), 119.76 (C-6’), 119.45 (C-
7’’), 118.95 (C-8), 118.56 (C-5), 112.36 (C-2’), 112.49 (C-6’), 111.37 (C-5’), 110.78 (C-3’’), 56.11 (4 x 
OMe), 47.74 (C-1’’). IR (vmax/cm
-1): 2970 (ArC-H); 1651 (C=N); 1454 (ArC=C); 1228 (C-O). 
4.7.19.2.  METHOD M 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a yellow oil (2.66 g, 66%). Rf (60% EtOAc/hexane) 
0.21. 
4.7.19.3.  METHOD O 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a white solid (0.927 g, 23%). Rf (60% EtOAc/hexane) 
0.21. 
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4.7.19.4.  METHOD P 
Denilite® II Base (0.085 g), stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a yellow oil (1.21 g, 
30%). Rf (60% EtOAc/hexane) 0.21. 
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4.8.  Synthesis of benzothiazoles 
The following methods were used to synthesize benzothiazoles  
Method Q 
A mixture of 2-aminothiophenol (1.63 g, 15.0 mmol) and benzaldehyde derivative (1.06 g, 10.0 mmol) 
in acetonitrile (10.0 mL) and acetate buffer (10.0 mL, pH 4.0) was stirred at room for 5 minutes. 
Suberase® (2.0 mL) was then added into the mixture and the contents were stirred for 1 h. When the 
reaction completes, the product precipitates from the solution and was extracted with ethyl acetate 
(30.0 mL) and water (3 x 20.0 mL) and concentrated on a rotary evaporator. The product was washed 
several times with cold acetonitrile (3 x 20.0 mL) to remove any excess starting material.  
Method R 
The same as Method Q, except that methanol (2.0 mL) was used instead of acetonitrile.  
Method S 
The same as Method Q, except that ethanol (4.0 mL) was used instead of acetonitrile.  
Method T 
The same as Method Q, except that DMF (10.0 mL) was used instead of acetonitrile.  
Method U 
The same as Method Q, except that DCM (10.0 mL) was used instead of acetonitrile. 
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4.8.1.  Synthesis of 2-phenylbenzothiazole (15a) 
 
4.8.1.1.  METHOD Q 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a bright yellow solid (1.79 g, 85%). Rf (40% 
EtOAc/hexane) 0.93. MP = 96 – 98 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.15 – 8.04 (3H, m, 
H8, H2’, H6’), 7.91 (1H, d, J = 8.0 Hz, H5), 7.50 (4H, m, H6, H7, H3’, H5’), 7.39 (1H, t, J = 7.6 Hz, 
H4’). 13C NMR (126 MHz, Chloroform-d): δ 154.17 (C-2), 135.08 (C-4), 133.65 (C-1’), 130.97 (C-9), 
129.03 (C-2’, C-6’), 127.57 (C-5’), 126.32 (C-3’), 125.19 (C-4’), 123.26 (C-6, C-7), 121.62 (C-5, C-8). IR 
(vmax/cm
-1): 3075 (ArC-H); 1588, 1558, (ArC=C); 1644 (C=N); 727 (C-S). 
4.8.1.2.  METHOD R 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a white solid (1.23 g, 58%). Rf (40% EtOAc/hexane) 
0.93. 
4.8.1.3.  METHOD S 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a white solid (1.16 g, 55%). Rf (40% EtOAc/hexane) 
0.93. 
4.8.1.4.  METHOD T 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a white solid (1.66 g, 78%). Rf (40% EtOAc/hexane) 
0.93. 
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4.8.1.5.  METHOD U 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a white solid (1.37 g, 65%). Rf (40% EtOAc/hexane) 
0.93. 
4.8.2.  Synthesis of 4-(benzothiazol-2-yl)-N,N-dimethylaniline (15b) 
 
4.8.2.1.  METHOD Q 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a cream solid (1.43 g, 56%). Rf (40% EtOAc/hexane) 
0.81. MP = 172 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.03 – 7.91 (2H, m, H2’, H6’), 7.84 (1H, 
d, J = 7.9 Hz, H5), 7.44 (1H, t, J = 7.4 Hz, H6), 7.30 (1H, t, J = 7.6 Hz, H7), 6.82 – 6.54 (3H, m, H8, 
H3’, H5’), 3.01 (6H, d, J = 53.2 Hz, N-CH3).
 13C NMR (126 MHz, Chloroform-d): δ 168.79 (C-2), 
154.43 (C-4’), 152.20 (C-4), 134.56 (C-9), 128.87 (C-6’), 127.71 (C-2’), 125.97 (C-6), 125.29 (C-7), 
124.18 (C-1’), 122.29(C-8), 121.34 (C-5), 120.46 (C-5’), 112.29(C-3’), 40.48 (N-CH3), 40.18 (N-CH3). 
IR (vmax/cm
-1): 3053 (ArC-H); 2904 (C-N); 2815 (N-C-H), 1556, 1526, (ArC=C); 1604 (C=N); 720 
(C-S). 
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4.8.3.  Synthesis of 2-(4-methoxyphenyl)benzothiazole (15c) 
 
4.8.3.1.  METHOD Q 
Stirring time = 8 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford white solid (1.64 g, 68%). Rf (40% EtOAc/hexane) 
0.89. MP = 120 – 122 °C.  1H NMR (500 MHz, Chloroform-d): δ 8.04 (3H, d, J = 8.7 Hz, H5, H2’, 
H6’), 7.88 (1H, d, J = 8.0 Hz, H8), 7.47 (1H, t, J = 7.6 Hz, H6), 7.35 (1H, t, J = 7.6 Hz, H7), 7.00 (2H, 
d, J = 8.7 Hz, H3’, H5’), 3.88 (3H, s, OMe). 13C NMR (126 MHz, Chloroform-d): δ 167.85 (C-2), 
161.94 (C-4’), 154.24 (C-4), 134.87 (C-1’), 129.12 (C-9), 126.47 (C-6’), 126.19 (C-2’), 124.79 (C-6), 
122.83 (C-7), 121.50 (C-5, C-8), 114.38 (C-3’, C-5’), 55.46 (OMe). IR (vmax/cm
-1): 3060 (ArC-H); 1574, 
1557, (ArC=C); 1603 (C=N); 729 (C-S), 1310 (C-O). 
4.8.4.  Synthesis of 2-(3,4-dimethoxyphenyl)benzothiazole (15d) 
 
4.8.4.1  METHOD Q 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a cream solid (1.98 g, 73%). Rf (40% EtOAc/hexane) 
0.67. MP = 132 – 134 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.04 (1H, d, J = 8.2 Hz, H5), 7.88 
(1H, d, J = 7.9 Hz, H8), 7.71 (1H, s, H2), 7.60 (1H, d, J = 9.5 Hz, H6’), 7.47 (1H, t, J = 7.7 Hz, H6), 
7.36 (1H, t, J = 7.6 Hz, H7), 6.95 (1H, d, J = 8.4 Hz, H5’), 3.99 (6H, d, J = 33.3 Hz, OMe). 13C NMR 
(126 MHz, Chloroform-d): δ 167.93 (C-2), 154.17 (C-4), 151.60 (C-3’), 149.37 (C-4’), 134.92 (C-9), 
126.71 (C-1’), 126.23 (C-6), 124.88 (C-7), 122.85 (C-5), 121.51 (C-8), 121.16 (C-6’), 111.05 (C-2’), 
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109.84 (C-5’), 56.15 (OMe-3’), 56.06 (OMe-4’). IR (vmax/cm
-1): 2964 (ArC-H); 1520, 1479, (ArC=C); 
1598 (C=N); 732 (C-S), 1312 (C-O). 
4.8.5.  Synthesis of 2-(3,4,5-trimethoxyphenyl)benzothiazole (15e) 
 
4.8.5.1.  METHOD Q 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a yellow solid (1.96 g, 65%). Rf (40% EtOAc/hexane) 
0.74. MP = 148 – 151 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.06 (1H, d, J = 8.2 Hz, H5), 7.89 
(1H, d, J = 8.0 Hz, H8), 7.49 (1H, t, J = 7.7 Hz, H6), 7.38 (1H, t, J = 7.6 Hz, H7), 7.34 (2H, s, H2’, 
H6’), 3.96 (9H, d, J = 30.7 Hz, OMe). 13C NMR (126 MHz, Chloroform-d): δ 167.80 (C-2), 154.10 
(C-4), 153.61 (C-3’, C-5’), 140.71 (C-4’), 135.06 (C-9), 129.09 (C-1’), 126.36 (C-6), 125.13 (C-7), 123.10 
(C-8), 121.56 (C-5), 104.84 (C-2’, C-6’), 61.02 (2 x OMe), 56.39 (OMe). IR (vmax/cm
-1): 2941 (ArC-H); 
1581, 1518, (ArC=C); 1698 (C=N); 1331 (C-O); 709 (C-S). 
4.8.6.  Synthesis of 2-(2-chlorophenyl)benzothiazole (15f) 
 
4.8.6.1.  METHOD Q 
Stirring time = 18 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a cream solid (1.35 g, 55%). Rf (40% EtOAc/hexane) 
0.93. MP = 110 – 112 °C. 1H NMR (500 MHz, Chloroform-d) δ 8.07 (1H, d, J = 8.2 Hz, H5), 8.03 
(2H, d, J = 8.4 Hz, H2’, H6’), 7.90 (1H, d, J = 8.0 Hz, H8), 7.48 (3H, m, H6, H3’, H5’), 7.40 (1H, t, J = 
7.6 Hz, H7).13C NMR (126 MHz, Chloroform-d) δ 166.60 (C-2), 154.08 (C-5), 137.03 (C-1’), 135.06 
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(C-4’), 132.13 (C-9), 129.27 (C-6’), 128.71 (C-2’), 126.48 (C-3’, C-5’), 125.41 (C-6), 123.31 (C-7), 121.65 
(C-5, C-8). IR (vmax/cm
-1): 3055 (ArC-H); 1646 (C=N); 1588, 1569, (ArC=C); 730 (C-Cl), 709 (C-S). 
4.8.7.  Synthesis of 2-(pyridin-4-yl)benzothiazole (15g) 
 
4.8.7.1.  METHOD Q 
Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a bright yellow solid (1.86 g, 88%). Rf (40% 
EtOAc/hexane) 0.37. MP = 126 – 130 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.78 (2H, d, J = 
5.7 Hz, H3’, H5’), 8.13 (1H, d, J = 8.2 Hz, H5), 7.99 – 7.87 (3H, m, H8, H2’, H6’), 7.55 (1H, t, J = 7.7 
Hz, H6), 7.46 (1H, t, J = 7.6 Hz, H7). 13C NMR (126 MHz, Chloroform-d): δ 165.10 (C-4), 153.99 
(C-2), 150.77 (C-3’, C-5’), 140.49 (C-1’), 135.23 (C-9), 126.82 (C-6), 126.20 (C-7), 123.94 (C-8), 121.87 
(C-5), 121.20 (C-2’, C-6’). IR (vmax/cm
-1): 3035 (ArC-H); 1698 (C=N); 1552, 1503, (ArC=C); 704 (C-
S). 
4.8.8.  Synthesis of 1,4-bis(benzothiazol-2-yl)benzene (15h) 
 
4.8.8.1.  METHOD Q 
2-aminothiophenol (2 equiv), Stirring time = 2 h. Purification by washing with cold acetonitrile (3 x 
20.0 mL) to remove any excess starting material (confirmed by TLC) to afford a yellow solid (2.98 g, 
87%). Rf (40% EtOAc/hexane) 0.81. MP = 261 – 264 °C.
 1H NMR (500 MHz, Chloroform-d): δ 
8.23 (4H, s, H2’, H3’, H5’, H6’), 8.12 (2H, d, J = 8.1 Hz, H5, H7’’), 7.94 (2H, d, J = 8.0 Hz, H8, H4’’), 
7.53 (2H, t, J = 7.6 Hz, H6, H6’’), 7.42 (2H, t, J = 7.5 Hz, H7, H5’’). 13C NMR (126 MHz, 
Chloroform-d): δ 166.81(C-2, C-1’’), 154.19 (C-4, C-8’’), 135.70 (C-1’, C-4’’), 135.21 (C-9, C-3’’), 
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128.09 (C-2’, C-3’, C-5’, C-6’), 126.56 (C-6, C-6’’), 125.56 (C-7, C-5’’), 123.48 (C-8, C-4’’), 121.70 (C-5, 
C-7’’). IR (vmax/cm
-1): 3057 (ArC-H); 1697 (C=N); 1558, 1522, (ArC=C); 724 (C-S). 
4.8.9.  Synthesis of 2-(2-bromo-5-methoxyphenyl)benzothiazole (15i) 
 
4.8.9.1.  METHOD Q 
Stirring time = 8 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a yellow solid (2.42 g, 76%). Rf (40% EtOAc/hexane) 
0.93. MP = 123 – 125 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.68 (1H, d, J = 2.3 Hz, H5), 8.10 
(1H, d, J = 8.2 Hz, H8), 7.93 (1H d, J = 7.9 Hz, H3’), 7.57 – 7.46 (2H, m, H6, H6’), 7.39 (1H, t, J = 7.5 
Hz, H7), 6.94 (1H, d, J = 8.8 Hz, H4’), 4.04 (3H, s, OMe). 13C NMR (126 MHz, Chloroform-d): δ 
161.43 (C-2), 156.22 (C-5’), 152.00 (C-4), 136.20 (C-1’), 134.12 (C-9), 131.88 (C-3’), 126.11 (C-6), 
124.93 (C-7), 124.05 (C-8), 122.99 (C-5), 121.24 (C-4’), 113.81 (C-6’), 113.46 (C-2’), 56.03 (OMe). IR 
(vmax/cm
-1): 3058 (ArC-H); 1694 (C=N); 1587, 1571, (ArC=C); 1315 (C-O); 751 (C-Br); 723 (C-S). 
4.8.10.  Synthesis of 2-(3-nitrophenyl)benzothiazole (15j) 
 
4.8.10.1.  METHOD Q 
Stirring time = 8 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a yellow solid (1.23 g, 48%). Rf (40% EtOAc/hexane) 
0.81. MP = 185 – 187 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.94 (1H, s, H2’), 8.43 (1H, d, J = 
7.8 Hz, H6’), 8.34 (1H, d, J = 8.2 Hz, H4’), 8.12 (1H, d, J = 8.2 Hz, H5), 7.95 (1H, d, J = 8.0 Hz, H8), 
7.69 (1H, t, J = 8.0 Hz, H5’), 7.55 (1H, t, J = 7.7 Hz, H6), 7.46 (1H, t, J = 7.6 Hz, H7). 13C NMR (126 
MHz, Chloroform-d): δ 164.89 (C-2), 153.97 (C-4), 148.79 (C-3’), 135.32 (C-6’), 135.20 (C-1’), 132.99 
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(C-9), 130.10 (C-5’), 126.84 (C-6), 126.03 (C-7), 125.18 (C-4’), 123.77 (C-2’), 122.35 (C-8), 121.83 (C-5). 
IR (vmax/cm
-1): 3085 (ArC-H); 1612 (C=N); 1579, 1547, (ArC=C); 1362 (N-O); 715 (C-S). 
4.8.11.  Synthesis of 2-(2-methoxyphenyl)benzothiazole (15k) 
 
4.8.11.1.  METHOD Q 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a brown solid (1.78 g, 74%). Rf (40% EtOAc/hexane) 
0.89. MP =121 °C. 1H NMR (500 MHz, Chloroform-d): δ 8.54 (1H, d, J = 7.8 Hz, H5), 8.10 (1H, d, 
J = 8.2 Hz, H8), 7.93 (1H, d, J = 7.9 Hz, H6’), 7.56 – 7.42 (2H, m, H6, H7), 7.37 (1H, t, J = 7.5 Hz, 
H5’), 7.14 (1H, t, J = 7.6 Hz, H4’), 7.06 (1H, d, J = 8.3 Hz, H3’), 4.05 (3H, s, OMe). 13C NMR (126 
MHz, Chloroform-d): δ 153.49 (C-2), 150.51 (C-2’), 148.80 (C-4), 137.60 (C-9), 134.06 (C-4’), 133.86 
(C-6’), 130.78 (C-6), 129.93 (C-7), 129.60 (C-1’), 125.66 (C-8), 123.29 (C-5), 116.28 (C-5’), 115.26 (C-
3’). IR (vmax/cm
-1): 3053 (ArC-H); 1604 (C=N); 1556, 1526, (ArC=C); 1315 (C-O); 720 (C-S). 
4.8.12.  Synthesis of 2-(4-nitrophenyl)benzothiazole (15l) 
 
4.8.12.1  METHOD Q 
Stirring time = 24 h. Purification by washing with cold acetonitrile (3 x 20.0 mL) to remove any excess 
starting material (confirmed by TLC) to afford a yellow solid (2.15 g, 84%). Rf (40% EtOAc/hexane) 
0.92. MP = 243 °C.  1H NMR (500 MHz, Chloroform-d): δ 8.36 (2H, d, J = 8.7 Hz, H3’, H5’), 8.27 
(2H, d, J = 8.7 Hz, H2’, H6’), 8.13 (1H, d, J = 8.2 Hz, H5), 7.96 (1H, d, J = 8.0 Hz, H8), 7.56 (1H, t, J 
= 7.7 Hz, H6), 7.47 (1H, t, J = 7.6 Hz, H7). 13C NMR (126 MHz, Chloroform-d): δ 164.84 (C-2), 
154.11 (C-4), 149.05 (C-1’), 139.19 (C-4’), 135.50 (C-9), 128.24 (C-2’, C-6’), 126.93 (C-6), 126.23 (C-7), 
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124.32 (C-3’), 123.95 (C-5’), 121.85 (C-5, C-8). IR (vmax/cm
-1): 3060 (ArC-H); 1603 (C=N); 1574, 
1557, (ArC=C); 1310 (N-O); 729 (C-S). 
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4.9.  Synthesis of diaminobenzoquinones 
Method U 
The primary amine (20.0 mmol, 2 equiv) was added to a mixture containing a dihydrobenzoquinone 
derivative (10.0 mmol, 1 equiv), acetonitrile (10.0 mL), acetate buffer (0.1 M, 10.0 mL, pH 4.0) and 
Denilite® II Base (0.085 g). The mixture was stirred at room temperature until the reaction completes 
(monitored by TLC). When the reaction completes, the product was extracted with ethyl acetate (30.0 
mL) and water (3 x 20.0 mL). After extraction, the solvent was removed on the rotary evaporator to 
afford a solid product and purified by flash chromatography.  
Method V 
The same as Method U, except that methanol (2.0 mL) was used instead of acetonitrile.  
Method W 
The same as Method U, except that DMF (10.0 mL) was used instead of acetonitrile.  
Method X 
The same as Method U, except that twice the solvent (acetonitrile, methanol, and DMF) and buffer 
were used.  
Method Y 
A repetition of method X using Novoprime Base 268 (0.105 g) and Suberase® (2.00 mL) 
Method Z 
The primary amine (20.0 mmol, 2 equiv) was added to a mixture containing, DMF (20.0 mL), acetate 
buffer (0.1 M, 20.0 mL, pH 4.0) and Novoprime Base 268 (0.105 g). The dihydroxy-benzoquinone 
derivative (10.0 mmol, 1 equiv) was dissolved in DMF and added dropwise into the mixture over time. 
The mixture was stirred at room temperature until the reaction completes (monitored by TLC). More 
laccase was added after 4, 12, and 18 h of reaction. When the reaction completes, the product was 
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extracted with ethyl acetate (30.0 mL) and water (3 x 20.0 mL). After extraction, the solvent was 
removed on the rotary evaporator to afford a solid product and purified by flash chromatography.  
4.9.1. Synthesis of 3-acetyl-2,5-bis((4-isopropylphenyl)amino)cyclohexa-2,5-diene-1,4-dione 
(18) 
 
4.9.1.1.  METHOD U 
Stirring time = 24 h. Purification by flash chromatography (silica/EtOAc-hexane, 1:4) to afford an 
orange brown solid (0.706 g, 17%). 
 
4.9.1.2.  METHOD V 
Stirring time = 24 h. Purification by flash chromatography (silica/EtOAc-hexane, 1:4) to afford an 
orange brown solid (0.498 g, 12%). 
4.9.1.3.  METHOD W 
Stirring time = 24 h. Purification by flash chromatography (silica/EtOAc-hexane, 1:4) to afford an 
orange brown solid (1.03 g, 25%). 
4.9.1.4.  METHOD Z 
Stirring time = 24 h. Purification by flash chromatography (silica/EtOAc-hexane, 1:4) to afford an 
orange brown solid (2.89 g, 72%).  Rf (40% EtOAc/hexane) 0.72. MP = 136 – 140 °C. 
1H NMR (500 
MHz, Chloroform-d): δ  8.39 (2H, s, NH), 7.29 (4H, d, J = 8.2 Hz, C-3’, C-5’, C-3’’, C-5’’), 7.18 (4H, 
d, J = 8.2 Hz, H2’, H6’, H2’’, H6’’), 6.10 (1H, s, H3), 2.93 (2H, h, J = 7.9, 7.4 Hz, H7’, H7’’), 2.65 (3H, 
s, CH3-8), 1.23 (12H, dd, J = 30.6, 6.9 Hz, 4 x CH3). 
13C NMR (126 MHz, Chloroform-d): δ 206.91 
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(C-7), 200.03 (C-4), 177.21 (C-1, C-5), 147.84 (C-1’, C-1’’), 134.21 (C-4’, C4’, C-2), 127.75 (C-3’, C-5’, 
C-3’’, C-5’’), 123.30 (C-2’, C-6’, C-2’’, C-6’’), 115.23 (C-6), 96.94 (C-3), 33.79 (C-7’, C-7’’), 32.52 (C-8), 
23.90 (4 x CH3). IR (vmax/cm
-1): 3221 (N-H); 2967 (ArC-H); 1738 (C=O); 1587, 1551, (ArC=C); 1328 
(C-N); 1206 (C-O). 
4.9.2.  Synthesis of 2-(phenylamino)cyclohexa-2,5-diene-1,4-dione (19) 
 
4.9.2.1.  METHOD Z 
Primary amine (10.0 mmol, 1 equiv). Stirring time = 24 h. washing with ethyl acetate (1 x 20.0 mL) to 
afford a dark brown solid (2.01 g, 100%). Rf (40% EtOAc/hexane). MP = 138 – 140 °C. 
1H NMR 
(300 MHz, Chloroform-d):  δ 10.38 (1H, s, H3), 8.56 – 8.25 (1H, m, NH), 7.69 (2H, s, H5, H6), 7.53 
– 7.46 (1H, m, H4’), 7.46 – 7.35 (2H, m, H3’, H5’), 7.35 – 7.27 (2H, m, H2’, H6’). 13C NMR (126 
MHz, Chloroform-d): δ 206.95 (C-1), 178.09 (C-4), 151.53 (C-2), 150.21 (C-1’), 135.80 (C-5, C-6), 
128.26 (C-2’, C-5’), 125.52 (C-2’, C-4’, C-6’), 92.76 (C-3). IR (vmax/cm
-1): 3270 (N-H); 2926 (ArC-H); 
1633 (C=O); 1589, 1560, (ArC=C); 1247 (C-N). 
4.9.3.  Synthesis of 2,5-bis((4-isopropylphenyl)amino)cyclohexa-2,5-diene-1,4-dione (20) 
 
4.9.3.1.  METHOD Z 
Stirring time = 24 h. Purification by flash chromatography (silica/EtOAc-hexane, 1:4) to afford a dark 
brown solid (2.09 g, 56%). Rf (40% EtOAc/hexane) 0.82. MP = 138 – 142 °C. 
1H NMR (500 MHz, 
Chloroform-d): δ 8.09 (2H, s, NH), 7.19 (4H, d, J = 8.1 Hz, H2’, H6’, H2’’, H6’’), 7.02 (1H, d, J = 8.1 
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Hz, H3’’), 6.71 (2H, s, H5’, H5’’), 6.64 (1H, d, J = 8.1 Hz, H3’), 6.02 (2H, s, H3, H6), 2.93 (2H, hept, J 
= 7.0 Hz, H7’, H7’’), 1.26 (12H, d, J = 6.9 Hz,4 x CH3). 
13C NMR (126 MHz, Chloroform-d): δ 
180.11 (C-1, C-4), 147.12 (C-2, C-5), 147.08 (C-1’, C-1’’), 134.73 (C-4’, C-4’’), 127.60 (C-3’, C-5’, C-3’’, 
C-5’’), 122.81 (C-2’, C-6’, C-2’’, C-6’’), 116.18 (C-3, C-6), 115.25, 33.75 (C-7’, C-7’’), 23.92 (4 x CH3). 
IR (vmax/cm
-1): 3236 (N-H); 2960 (ArC-H); 1634 (C=O); 1560, 1512, (ArC=C); 1293 (C-N); 1185 (C-
O). 
4.9.4.  Synthesis of methyl 2,5-bis((4-isopropylphenyl)amino)-3,6-dioxocyclohexa-1,4-
dienecarboxylate (21) 
 
4.9.4.1.  METHOD Z 
Purification by flash chromatography (silica/EtOAc-hexane, 1:4) to afford a dark brown solid (1.21 g, 
28%). Rf (40% EtOAc/hexane) 0.69. MP = 190 – 192 °C. 
1H NMR (500 MHz, Chloroform-d): δ 
8.63 (1H, s, NH), 8.18 (1H, s, NH), 7.30 – 7.25 (4H, m, H3’, H5’, H3’’, H5’’), 7.18 (2H, d, J = 8.2 Hz, 
H2’, H6’), 7.07 (2H, d, J = 8.2 Hz, H2’’, H6’’), 6.23 (1H, s, H3), 3.11 (3H, s, CH3-9), 2.93 (2H, dq, J = 
13.4, 6.8 Hz, H7’, H7’’), 1.25 (12H, dd, J = 8.3, 7.0 Hz, 4 x CH3 ). 
13C NMR (126 MHz, Chloroform-
d): δ 206.90 (C-4), 178.48 (C-5), 177.01 (C-1), 148.27 (C-7), 147.58 (C-2), 147.07 (C-1’, C-1’’) 134.35 
(C-4’, C-4’’), 127.68 (C-3’, C-5’, C-3’’, C-5’’), 127.30 (C-2’, C-6’, C-2’’, C-6’’), 123.80 (C-3), 123.14 (C-6), 
51.30 (C-9), 33.78 (C-7’, C-7’’), 23.91 (4 x CH3). IR (vmax/cm
-1): 3225 (N-H); 2959 (ArC-H); 1723 
(C=O); 1589, 1560, (ArC=C); 1312 (C-N); 1259 (C-O). 
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4.9.5.  Synthesis of ethyl 3,6-dioxo-2,5-bis(phenylamino)cyclohexa-1,4-dienecarboxylate 
(22) 
 
4.9.5.1.  METHOD Z 
Stirring time = 24 h. Purification by washing with ethyl acetate (1 x 20.0 mL) to afford a dark brown 
solid (3.61 g, 100%). Rf (40% EtOAc/hexane). 0.72. MP = 160 – 163 °C.
 1H NMR (500 MHz, 
Chloroform-d): δ 8.69 (1H, s, NH), 8.19 (1H, s, NH), 7.46-7.37 (4H, m, H3’, H5’, H3’’, H5’’), 7.31 – 
7.23 (4H, m, H2’, H6’, H2’’, H6’’), 7.18 (2H, d, J = 7.8 Hz, H4’, H4’’), 6.11 (1H, s, H3), 3.55 (2H, q, J 
= 7.2 Hz, H9), 1.00 (3H, t, J = 7.2 Hz, H10). 13C NMR (126 MHz, Chloroform-d): δ 178.84 (C-4), 
177.21 (C-5), 164.29 (C-1), 146.70 (C-7), 137.36 (C-2), 136.79 (C-1’, C-1’’), 129.75 (C-3’, C-5’), 129.32 
(C-3’’, C-5’’), 127.14 (C-4’), 126.49 (C-4’’), 123.76 (C-2’, C-6’), 123.05 (C-2’’, C-6’’), 102.73 (C-3), 95.89 
(C-6), 60.92 (C-9), 13.80 (C-10). IR (vmax/cm
-1): 3242 (N-H); 1721 (C=O); 1555, 1495 (ArC=C); 1339 
(C-N); 1164 (C-O). 
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APPENDIX 
Spectra of selected compound are listed below.  
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